Document:

EX-4.2

 Exhibit 4.2 
 MARRONE BIO INNOVATIONS, INC. 
 SECOND AMENDED AND RESTATED INVESTOR
RIGHTS AGREEMENT 
 THIS SECOND AMENDED AND
RESTATED INVESTOR RIGHTS AGREEMENT (the “Agreement”) is made and entered into as of March 5, 2010, by and among MARRONE BIO INNOVATIONS, INC., a
Delaware corporation (the “Company”), the persons and entities holding shares of the Company’s Series A Preferred Stock (“Series A Stock”) listed on Exhibit A hereto (the
“Series A Investors”), the persons and entities holding shares of the Company’s Series B Preferred Stock (“Series B Stock”) listed on Exhibit B hereto (the “Series B
Investors”), the persons and entities holding shares of the Company’s Series C Preferred Stock (“Series C Stock”) listed on Exhibit C hereto (the “Series C Investors” and
collectively with the Series A Investors and the Series B Investors, the “Investors”) and each of Pamela G. Marrone, Julie I. Morris, Richard C. Dorf and Richard E. Rominger (the “Founders”).

 RECITALS 
 WHEREAS, the Series A Investors, the Series B Investors and the Founders are parties to that certain Amended and Restated Investor Rights Agreement (the “Prior IR
Agreement”) dated as of August 5, 2008. 
 WHEREAS, the Series C Investors are
purchasing shares of the Company’s Series C Stock pursuant to that certain Series C Preferred Stock Purchase Agreement (the “Purchase Agreement”) of even date herewith (the “Financing”).

 WHEREAS, the obligations in the Purchase Agreement are conditioned upon the execution
and delivery of this Agreement by the Series C Investors, the Series B Investors, the Series A Investors, the Founders and the Company; and 
 WHEREAS, in connection with the consummation of the Financing, the parties desire to enter into this Agreement in order to grant registration rights, information
rights and other rights to the Investors as set forth below, and the Series B Investors, the Series A Investors, the Founders and the Company desire to amend and restate the Prior IR Agreement as set forth herein. 

AGREEMENT 
 NOW, THEREFORE, in consideration of these premises and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the
parties hereto agree as follows: 

  
 1. 

	1.	GENERAL. 

1.1 Definitions. As used in this Agreement, the following terms shall have the following respective meanings: 

(a) “Exchange Act” means the Securities Exchange Act of 1934, as amended. 

(b) “Founders Stock” means shares of Common Stock of the Company held by the Founders as of the date
hereof or hereafter acquired (but excluding any Shares and any Common Stock issued or issuable on conversion of any Shares). 

(c) “Form S-3” means such form under the Securities Act as in effect on the date hereof or any successor
or similar registration form under the Securities Act subsequently adopted by the SEC which permits inclusion or incorporation of substantial information by reference to other documents filed by the Company with the SEC. 

(d) “Holder” means any person owning of record Registrable Securities that have not been sold to the
public, or any assignee of record of such Registrable Securities in accordance with Section 2.10 hereof. 
 (e)
“Initial Offering” means the Company’s first firm commitment underwritten public offering of its Common Stock registered under the Securities Act. 

(f) “Qualified IPO” means a firmly underwritten public offering pursuant to an effective registration
statement under the Securities Act covering the offer and sale of Common Stock of the Company for the account of the Company in which (i) the per share price is at least $3.3880304 (as adjusted for stock splits, dividends, recapitalizations and
the like after the filing date hereof), and (ii) the gross cash proceeds to the Company (before underwriting discounts, commissions and fees) are at least $30,000,000.00. 
 (g) “Register,” “registered,” and “registration” refer to a registration effected by preparing and filing a
registration statement in compliance with the Securities Act, and the declaration or ordering of effectiveness of such registration statement or document. 
 (h) “Registrable Securities” means (i) Common Stock of the Company issuable or issued upon conversion of the Shares, (ii) the Founders Stock; provided, however,
that for purposes of Section 2.2, 2.4 and 2.12 the Founders Stock shall not be deemed Registrable Securities and the Founders shall not be deemed Holders and (iii) any Common Stock of the Company issued as (or issuable upon the conversion
or exercise of any warrant, right or other security which is issued as) a dividend or other distribution with respect to, or in exchange for or in replacement of, such above-described securities. Notwithstanding the foregoing, Registrable Securities
shall not include any securities (A) sold to the public either pursuant to a registration statement or Rule 144, (B) sold in a private transaction in which the transferor’s rights under Section 2 of this Agreement are not
assigned or (C) held by a Holder (together with its affiliates), if the Company has completed its Initial Offering and all shares of Common Stock of the Company issuable or issued upon conversion of the Shares held by and issuable to such
Holder (and its affiliates) may be sold pursuant to Rule 144 during any 90 day period. 

  
 2. 

 (i) “Registrable Securities then outstanding” shall be the
number of shares of the Company’s Common Stock that are Registrable Securities and either (a) are then issued and outstanding or (b) are issuable pursuant to then exercisable or convertible securities. 

(j) “Registration Expenses” shall mean all expenses other than underwriting discounts and commissions
incurred by the Company in complying with Sections 2.2, 2.3 and 2.4 hereof, including, without limitation, all registration and filing fees, printing expenses, fees and disbursements of counsel for the Company, reasonable fees and disbursements
not to exceed $30,000 of a single special counsel for the Holders, blue sky fees and expenses and the expense of any special audits incident to or required by any such registration (but excluding the compensation of regular employees of the Company,
which shall be paid in any event by the Company). 
 (k) “Restated Charter” shall have the
meaning set forth in the Purchase Agreement. 
 (l) “SEC” or “Commission”
means the Securities and Exchange Commission. 
 (m) “Securities Act” shall mean the
Securities Act of 1933, as amended. 
 (n) “Selling Expenses” shall mean all underwriting
discounts, selling commissions and stock transfer taxes applicable to any registrations hereunder. 
 (o)
“Shares” shall mean the Series A Stock held by the Investors listed on Exhibit A hereto, the Series B Stock held by the Investors listed on Exhibit B hereto and the Series C Stock held by the Investors
listed on Exhibit C hereto, and their permitted assigns. 
 (p) “Special Registration
Statement” shall mean a registration statement relating to (i) any employee benefit plan, (ii) any corporate reorganization or transaction under Rule 145 of the Securities Act, including any registration statement related
to the issuance or resale of securities issued in such a transaction, (iii) stock issued upon conversion of debt securities, or (iv) a registration on any registration form that does not permit secondary sales. 

 

	2.	REGISTRATION; RESTRICTIONS ON TRANSFER. 

2.1 Restrictions on Transfer. 
 (a) Each Holder agrees not to make any disposition of all or any portion of the Shares or Registrable Securities held by such Holder unless and until: 

(i) there is then in effect a registration statement under the Securities Act covering such proposed disposition and such
disposition is made in accordance with such registration statement; or 
 (ii) (A) The transferee has agreed in
writing to be bound by the terms of this Agreement, (B) such Holder shall have notified the Company of the proposed disposition 

  
 3. 

 
and shall have furnished the Company with a detailed statement of the circumstances surrounding the proposed disposition, and (C) if requested by the Company, such Holder shall have
furnished the Company, at such Holder’s expense, with an opinion of counsel, reasonably satisfactory to the Company, that such disposition will not require registration of such shares under the Securities Act. After its Initial Offering, the
Company will not require any transferee pursuant to Rule 144 to be bound by the terms of this Agreement if the shares so transferred do not remain Registrable Securities hereunder following such transfer. 

(b) Notwithstanding the provisions of subsection (a) above, no such restriction shall apply to a transfer by a Holder that is
(A) a partnership transferring to its partners or former partners in accordance with partnership interests, (B) a corporation transferring to a wholly-owned subsidiary or a parent corporation that owns all of the capital stock of the
Holder, (C) a limited liability company transferring to its members or former members in accordance with their membership interests, (D) an individual transferring to the Holder’s family member or trust for the benefit of an
individual Holder or family member or members or (E) transferring to an entity affiliated by common control (or other related entity) with such Holder; provided that in each case the transferee will agree in writing to be subject to the
terms of this Agreement to the same extent as if he were an original Holder hereunder. 
 (c) Each certificate
representing Shares or Registrable Securities shall be stamped or otherwise imprinted with legends substantially similar to the following (in addition to any legend required under applicable state securities laws): 

THE SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE
“ACT”), AND MAY NOT BE OFFERED, SOLD OR OTHERWISE TRANSFERRED, ASSIGNED, PLEDGED OR HYPOTHECATED UNLESS AND UNTIL REGISTERED UNDER THE ACT OR UNLESS THE COMPANY HAS RECEIVED AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO
THE COMPANY AND ITS COUNSEL THAT SUCH REGISTRATION IS NOT REQUIRED. 
 THE SALE, PLEDGE, HYPOTHECATION OR TRANSFER OF THE
SECURITIES REPRESENTED BY THIS CERTIFICATE IS SUBJECT TO THE TERMS AND CONDITIONS OF A CERTAIN SECOND AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT BY AND BETWEEN THE STOCKHOLDER AND THE COMPANY. COPIES OF SUCH AGREEMENT MAY BE OBTAINED UPON
WRITTEN REQUEST TO THE SECRETARY OF THE COMPANY. 
 (d) The Company shall be obligated to promptly reissue unlegended
certificates at the request of any Holder thereof if the Company has completed its Initial Offering and if the Holder shall have obtained an opinion of counsel (which counsel may be counsel to the

  
 4. 

 
Company) reasonably acceptable to the Company to the effect that the securities proposed to be disposed of may lawfully be so disposed of without registration, qualification and legend.

 (e) Any legend endorsed on an instrument pursuant to applicable state securities laws and the stop-transfer
instructions with respect to such securities shall be removed upon receipt by the Company of an order of the appropriate blue sky authority authorizing such removal. 
 2.2 Demand Registration. 
 (a) Subject to the conditions of this
Section 2.2, if the Company shall receive a written request from the Holders of more than 40% of the Registrable Securities then outstanding (the “Initiating Holders”) that the Company file a registration statement under
the Securities Act covering the registration of Registrable Securities with an anticipated aggregate offering price before underwriting discounts and commissions, of not less than $10,000,000, then the Company shall promptly give written notice of
such request to all Holders, and subject to the limitations of this Section 2.2, shall effect, as expeditiously as reasonably possible, the registration under the Securities Act of all Registrable Securities that the Initiating Holders request
to be registered, together with all Registrable Securities of any other Holder or Holders joining in such request as are specified in a written request given within 15 days after receipt of such written notice from the Company. 

(b) If the Initiating Holders intend to distribute the Registrable Securities covered by a request made pursuant to this
Section 2.2, or any request pursuant to Section 2.4, by means of an underwriting, they shall so advise the Company as part of such request and the Company shall include such information in the written notice referred to in
Section 2.2(a) or Section 2.4(a), as applicable. In such event, the right of any Holder to include its Registrable Securities in such registration shall be conditioned upon such Holder’s participation in such underwriting and the
inclusion of such Holder’s Registrable Securities in the underwriting to the extent provided herein. All Holders proposing to distribute their securities through such underwriting shall enter into an underwriting agreement in customary form
with the underwriter or underwriters selected for such underwriting by a majority in interest of the Initiating Holders (which underwriter or underwriters shall be reasonably acceptable to the Company). Notwithstanding any other provision of this
Section 2.2 or Section 2.4, if the underwriter advises the Company that marketing factors require a limitation of the number of securities to be underwritten (including Registrable Securities), then the Company shall so advise all Holders
of Registrable Securities which would otherwise be underwritten, and the number of shares that may be included in the underwriting shall be allocated to the Holders of such Registrable Securities on a pro rata basis based on the number of
Registrable Securities held by all such Holders (including the Initiating Holders); provided, however, that the number of shares of Registrable Securities to be included in such underwriting and registration shall not be reduced unless
all other securities of the Company (including securities to be issued by the Company) are first entirely excluded from the underwriting and registration. Any Registrable Securities excluded or withdrawn from such underwriting shall be withdrawn
from the registration. 

  
 5. 

 (c) The Company shall not be required to effect a registration pursuant to this
Section 2.2: 
 (i) prior to the earlier of (A) the third anniversary of the date of this Agreement or
(B) 180 days following the effective date of the registration statement pertaining to the Initial Offering; 
 (ii)
after the Company has effected two registrations pursuant to this Section 2.2, and such registrations have been declared or ordered effective; 
 (iii) during the period starting with the date of filing of, and ending on the date 180 days following the effective date of a registration statement pertaining to a registered public offering of
the Company’s securities; provided that the Company makes reasonable good faith efforts to cause such registration statement to become effective; 
 (iv) if within 30 days of receipt of a written request from Initiating Holders pursuant to Section 2.2(a), the Company gives notice to the Holders of the Company’s intention to file a
registration statement for a registered public offering of the Company’s securities within 90 days; provided that the Company makes reasonable good faith efforts to cause such registration statement to be filed and become effective;

 (v) if the Company shall furnish to the Initiating Holders requesting a registration statement pursuant to this
Section 2.2(a) a certificate signed by the Chairman of the Board (or if none, the President of the Company) stating that in the good faith judgment of the Board of Directors of the Company, it would be materially detrimental to the Company and
its stockholders for such registration statement to be effected at such time, in which event the Company shall have the right to defer such filing for a period of not more than 90 days after receipt of the written request of the Initiating Holders;
provided that such right to delay a request shall be exercised by the Company not more than once in any 12 month period; and provided, further, that the Company may not register any shares for its own account or for the account
of others during such 90 day period; 
 (vi) if the Initiating Holders propose to dispose of shares of Registrable
Securities that may be immediately registered on Form S-3 pursuant to a request made pursuant to Section 2.4 below; or 
 (vii) in any particular jurisdiction in which the Company would be required to qualify to do business or to execute a general consent to service of process in effecting such registration,
qualification or compliance. 
 2.3 Piggyback Registrations. The Company shall notify all Holders of Registrable
Securities in writing at least 15 days prior to the filing of any registration statement under the Securities Act for purposes of a public offering of securities of the Company (including, but not limited to, registration statements relating to
secondary offerings of securities of the Company, but excluding Special Registration Statements) and will afford each such Holder an opportunity to include in such registration statement all or part of such Registrable Securities held by such
Holder. Each Holder desiring to include in any such registration statement all or any part of the Registrable Securities held by it shall, within 15 days after the above-described notice from the

  
 6. 

 
Company, so notify the Company in writing. Such notice shall state the intended method of disposition of the Registrable Securities by such Holder. If a Holder decides not to include all of its
Registrable Securities in any registration statement thereafter filed by the Company, such Holder shall nevertheless continue to have the right to include any Registrable Securities in any subsequent registration statement or registration statements
as may be filed by the Company with respect to offerings of its securities, all upon the terms and conditions set forth herein. 

(a) Underwriting. If the registration statement under which the Company gives notice under this Section 2.3 is for an
underwritten offering, the Company shall so advise the Holders of Registrable Securities. In such event, the right of any such Holder to include Registrable Securities in a registration pursuant to this Section 2.3 shall be conditioned upon
such Holder’s participation in such underwriting and the inclusion of such Holder’s Registrable Securities in the underwriting to the extent provided herein. All Holders proposing to distribute their Registrable Securities through such
underwriting shall enter into an underwriting agreement in customary form with the underwriter or underwriters selected for such underwriting by the Company. Notwithstanding any other provision of this Agreement, if the underwriter determines that
marketing factors require a limitation of the number of shares to be underwritten, the number of shares that may be included in the underwriting shall be allocated, first, to the Company; second, to the Holders (excluding Founders Stock held by the
Founders) on a pro rata basis based on the total number of Registrable Securities held by the Holders; and third, to the Founders (as to Founders Stock) and any other stockholders of the Company (other than the Holders) on a pro rata
basis based on the total number of Company securities held by such holders; provided, however, that no such reduction shall reduce the amount of securities of the selling Holders included in the registration below 30% of the total amount of
securities included in such registration, unless such offering is a Qualified IPO and such registration does not include shares of any other selling stockholders, in which event any or all of the Registrable Securities of the Holders may be excluded
in accordance with the immediately preceding clause. In no event will shares of any other selling stockholder be included in such registration that would reduce the number of shares which may be included by Holders without the written consent of
Holders of not less than a majority of the Registrable Securities proposed to be sold in the offering. If any Holder disapproves of the terms of any such underwriting, such Holder may elect to withdraw therefrom by written notice to the Company and
the underwriter, delivered at least 10 days prior to the effective date of the registration statement. Any Registrable Securities excluded or withdrawn from such underwriting shall be excluded and withdrawn from the registration. For any Holder that
is a partnership, limited liability company or corporation, the partners, retired partners, members, retired members, stockholders and affiliates of such Holder, and the estates and family members of any such partners, retired partners, members or
retired members and any trusts for the benefit of any of the foregoing persons shall be deemed to be a single “Holder,” and any pro rata reduction with respect to such “Holder” shall be based upon the aggregate amount of
Registrable Securities owned by all entities and individuals deemed to be such single “Holder” as provided in this sentence. 
 (b) Right to Terminate Registration. The Company shall have the right to terminate or withdraw any registration initiated by it under this Section 2.3 prior to the effectiveness of such
registration whether or not any Holder has elected to include securities in such registration and shall promptly notify any Holder that has elected to include securities in 

  
 7. 

 
such registration of such termination or withdrawal. The Registration Expenses, if any, of such withdrawn registration shall be borne by the Company in accordance with Section 2.5 hereof.

 2.4 Form S-3 Registration. After the Company has qualified for use of Form S-3, if the Company shall receive a written
request from any Holder or Holders of more than 10% of the Registrable Securities then outstanding (the “S-3 Initiating Holders”) that the Company effect a registration on Form S-3 and any related qualification or
compliance with respect to all or a part of the Registrable Securities owned by such S-3 Initiating Holder or Holders, the Company will: 
 (a) promptly give written notice of the proposed registration, and any related qualification or compliance, to all other Holders of Registrable Securities; and 

(b) as soon as practicable, effect such registration and all such qualifications and compliances as may be so requested and as
would permit or facilitate the sale and distribution of all or such portion of such S-3 Initiating Holders’ Registrable Securities as are specified in such request, together with all or such portion of the Registrable Securities of any other
Holder or Holders joining in such request as are specified in a written request given within 20 days after receipt of such written notice from the Company; provided, however, that the Company shall not be obligated to effect any such
registration, qualification or compliance pursuant to this Section 2.4: 
 (i) if Form S-3 is not available for
such offering by the S-3 Initiating Holders; 
 (ii) if the S-3 Initiating Holders, together with the holders of any
other securities of the Company entitled to inclusion in such registration, propose to sell Registrable Securities and such other securities (if any) at an aggregate price to the public of less than $1,500,000; 

(iii) if within 30 days of receipt of a written request from any S-3 Initiating Holders pursuant to this Section 2.4, the
Company gives notice to such S-3 Initiating Holders of the Company’s intention to make a public offering within 90 days, other than pursuant to a Special Registration Statement; provided that the Company makes reasonable good faith
efforts to cause such registration statement to be filed and become effective; 
 (iv) if the Company shall furnish to
the S-3 Initiating Holders requesting a registration statement pursuant to this Section 2.4 a certificate signed by the Chairman of the Board (or if none, the President of the Company) stating that in the good faith judgment of the Board of
Directors of the Company, it would be materially detrimental to the Company and its stockholders for such Form S-3 registration to be effected at such time, in which event the Company shall have the right to defer such filing for a period of not
more than 90 days after receipt of the written request of the Initiating Holders; provided that such right to delay a request shall be exercised by the Company not more than once in any 12 month period; and provided, further,
that the Company may not register any shares for its own account or for the account of others during such 90 day period; 

(v) if the Company has, within the 12 month period preceding the date of such request, already effected two registrations on
Form S-3 pursuant to this Section 2.4; or 

  
 8. 

 (vi) in any particular jurisdiction in which the Company would be required to
qualify to do business or to execute a general consent to service of process in effecting such registration, qualification or compliance. 
 (c) Subject to the foregoing, the Company shall file a Form S-3 registration statement covering the Registrable Securities and other securities so requested to be registered as soon as
practicable after receipt of the requests of the S-3 Initiating Holders. Registrations effected pursuant to this Section 2.4 shall not be counted as demands for registration or registrations effected pursuant to Section 2.2. 

2.5 Expenses of Registration. Except as specifically provided herein, all Registration Expenses incurred in connection with any
registration, qualification or compliance pursuant to Section 2.2, or any registration under Section 2.3 or Section 2.4 herein, shall be borne by the Company. All Selling Expenses incurred in connection with any registrations
hereunder, shall be borne by the holders of the securities so registered pro rata on the basis of the number of shares so registered. The Company shall not, however, be required to pay for expenses of any registration proceeding begun
pursuant to Section 2.2 or 2.4, the request of which has been subsequently withdrawn by the requisite Holders (including because a sufficient number of Holders shall have withdrawn from the registration so that the minimum offering conditions
set forth in Section 2.2 and 2.4 are no longer satisfied), unless (a) the withdrawal is based upon material adverse information concerning the Company of which the requisite Holders were not aware at the time of such request, or
(b) in the case of a registration requested pursuant to Section 2.2, the Holders of a majority of the Registrable Securities agree to forfeit their right to one requested registration pursuant to Section 2.2, in which event such right
shall be forfeited by all Holders. If the Holders are required to pay the Registration Expenses, such expenses shall be borne by the holders of securities (including Registrable Securities) requesting such registration in proportion to the number of
shares for which registration was requested. If the Company is required to pay the Registration Expenses of a withdrawn offering pursuant to clause (a) above, then the Holders shall not forfeit their right to one requested registration pursuant
to Section 2.2. 
 2.6 Obligations of the Company. Whenever required to effect the registration of any Registrable
Securities, the Company shall, as expeditiously as reasonably possible: 
 (a) Prepare and file with the SEC a
registration statement with respect to such Registrable Securities and use all reasonable efforts to cause such registration statement to become effective as expeditiously as possible, and, upon the request of the Holders of a majority of the
Registrable Securities registered thereunder, keep such registration statement effective for up to 120 days or, if earlier, until the Holder or Holders have completed the distribution related thereto; provided, however, that (i) such
120-day period shall be extended for a period of time equal to the period a Holder refrains from selling any securities included in such registration at the request of an underwriter of Common Stock (or other securities) of the Company; and
(ii) in the case of any registration of Registrable Securities on Form S-3 which are intended to be offered on a continuous or delayed basis, subject to compliance with applicable SEC rules, such 120-day period shall be extended for up to
ninety (90) days, if necessary, to keep the registration statement effective until all such Registrable Securities are sold; provided, further, however, that at any time, upon written notice to the participating Holders and for a period
not to exceed 60 

  
 9. 

 
days thereafter (the “Suspension Period”), the Company may delay the filing or effectiveness of any registration statement or suspend the use or effectiveness of any
registration statement (and the Holders hereby agree not to offer or sell any Registrable Securities pursuant to such registration statement during the Suspension Period) if the Company reasonably believes that there is or may be in existence
material nonpublic information or events involving the Company, the failure of which to be disclosed in the prospectus included in the registration statement could result in a Violation (as defined below). In the event that the Company shall
exercise its right to delay or suspend the filing or effectiveness of a registration hereunder, the applicable time period during which the registration statement is to remain effective shall be extended by a period of time equal to the duration of
the Suspension Period. The Company may extend the Suspension Period for an additional consecutive 60 days with the consent of the holders of a majority of the Registrable Securities registered under the applicable registration statement, which
consent shall not be unreasonably withheld. No more than two such Suspension Periods shall occur in any 12 month period. In no event shall any Suspension Period, when taken together with all prior Suspension Periods, exceed 120 days in the
aggregate. If so directed by the Company, all Holders registering shares under such registration statement shall (i) not offer to sell any Registrable Securities pursuant to the registration statement during the period in which the delay
or suspension is in effect after receiving notice of such delay or suspension and (ii) use reasonable efforts to deliver to the Company (at the Company’s expense) all copies, other than permanent file copies then in such Holders’
possession, of the prospectus relating to such Registrable Securities current at the time of receipt of such notice. 
 (b)
Prepare and file with the SEC such amendments and supplements to such registration statement and the prospectus used in connection with such registration statement as may be necessary to comply with the provisions of the Securities Act with
respect to the disposition of all securities covered by such registration statement for the period set forth in subsection (a) above. 
 (c) Furnish to the Holders such number of copies of a prospectus, including a preliminary prospectus, in conformity with the requirements of the Securities Act, and such other documents as they may
reasonably request in order to facilitate the disposition of Registrable Securities owned by them. 
 (d) Use its
reasonable efforts to register and qualify the securities covered by such registration statement under such other securities or Blue Sky laws of such jurisdictions as shall be reasonably requested by the Holders; provided that the Company
shall not be required in connection therewith or as a condition thereto to qualify to do business or to file a general consent to service of process in any such states or jurisdictions. 

(e) In the event of any underwritten public offering, enter into and perform its obligations under an underwriting agreement, in
usual and customary form, with the managing underwriter(s) of such offering. Each Holder participating in such underwriting shall also enter into and perform its obligations under such an agreement. 

(f) Notify each Holder of Registrable Securities covered by such registration statement, at any time when a prospectus relating
thereto is required to be delivered under the Securities Act, of the happening of any event as a result of which the prospectus included in such 

  
 10.

 
registration statement, as then in effect, includes an untrue statement of a material fact or omits to state a material fact required to be stated therein or necessary to make the statements
therein not misleading in the light of the circumstances then existing. The Company will use reasonable efforts to amend or supplement such prospectus in order to cause such prospectus not to include any untrue statement of a material fact or omit
to state a material fact required to be stated therein or necessary to make the statements therein not misleading in the light of the circumstances then existing. 
 (g) Use its reasonable efforts to furnish, on the date that such Registrable Securities are delivered to the underwriters for sale, if such securities are being sold through underwriters,
(i) an opinion, dated as of such date, of the counsel representing the Company for the purposes of such registration, in form and substance as is customarily given to underwriters in an underwritten public offering, addressed to the
underwriters, if any, and (ii) a letter, dated as of such date, from the independent certified public accountants of the Company, in form and substance as is customarily given by independent certified public accountants to underwriters in an
underwritten public offering addressed to the underwriters. 
 (h) Cause all such Registrable Securities registered
pursuant hereunder to be listed on each securities exchange on which similar securities issued by the Company are then listed; provided that in the case of a registration effected pursuant to Section 2.2 above, which registration
constitutes the Initial Offering, the Registrable Securities will be listed on a national securities exchange. 
 (i)
Provide a transfer agent and registrar for all Registrable Securities registered pursuant hereunder and a CUSIP number for all such Registrable Securities, in each case not later than the effective date of such registration. 

2.7 Termination of Registration Rights. All registration rights granted under this Section 2 shall terminate and be of no
further force and effect with respect to any Holder on the earlier of (a) such date, on or after a Qualified IPO, on which all shares of Registrable Securities held by such Holder (and any subsidiaries, parents, partners, limited partners,
retired partners, members, retired members, stockholders, affiliates or entities under common investment management with such Holder with whom such Holder must aggregate its sales under SEC Rule 144) may immediately be sold under Rule 144 during any
90 day period, (b) the closing of an “Acquisition” or “Asset Transfer” (each as defined in the Restated Charter) or (c) 5 years after the closing of a Qualified IPO. 

2.8 Delay of Registration; Furnishing Information. 
 (a) No Holder shall have any right to obtain or seek an injunction restraining or otherwise delaying any such registration as the result of any controversy that might arise with respect to the
interpretation or implementation of this Section 2. 
 (b) It shall be a condition precedent to the obligations of
the Company to take any action pursuant to Section 2.2, 2.3 or 2.4 that the selling Holders shall furnish to the Company such information regarding themselves, the Registrable Securities held by them and

  
 11.

 
the intended method of disposition of such securities as shall be reasonably required to effect the registration of their Registrable Securities. 

(c) The Company shall have no obligation with respect to any registration requested pursuant to Section 2.2 or
Section 2.4 if, due to the operation of subsection 2.2(b), the number of shares or the anticipated aggregate offering price of the Registrable Securities to be included in the registration does not equal or exceed the number of shares or
the anticipated aggregate offering price required to originally trigger the Company’s obligation to initiate such registration as specified in Section 2.2 or Section 2.4, whichever is applicable. 

2.9 Indemnification. In the event any Registrable Securities are included in a registration statement under Sections 2.2, 2.3
or 2.4: 
 (a) To the extent permitted by law, the Company will indemnify and hold harmless each Holder, the partners,
members, legal counsel, accountants, officers and directors of each Holder, any underwriter (as defined in the Securities Act) for such Holder and each person, if any, who controls such Holder or underwriter within the meaning of the Securities Act
or the Exchange Act, against any losses, claims, damages, or liabilities (joint or several) to which they may become subject under the Securities Act, the Exchange Act or other federal or state law, insofar as such losses, claims, damages or
liabilities (or actions in respect thereof) arise out of or are based upon any of the following statements, omissions or violations (collectively a “Violation”) by the Company: (i) any untrue statement or alleged untrue
statement of a material fact contained in such registration statement or incorporated by reference therein, including any preliminary prospectus or final prospectus contained therein or any amendments or supplements thereto, (ii) the omission
or alleged omission to state therein a material fact required to be stated therein, or necessary to make the statements therein not misleading, or (iii) any violation or alleged violation by the Company of the Securities Act, the Exchange Act,
any state securities law or any rule or regulation promulgated under the Securities Act, the Exchange Act or any state securities law in connection with the offering covered by such registration statement; and the Company will reimburse each such
Holder, partner, member, legal counsel, accountant, officer, director, underwriter or controlling person for any legal or other expenses reasonably incurred by them in connection with investigating or defending any such loss, claim, damage,
liability or action; provided however, that the indemnity agreement contained in this Section 2.9(a) shall not apply to amounts paid in settlement of any such loss, claim, damage, liability or action if such settlement is effected
without the consent of the Company, which consent shall not be unreasonably withheld, nor shall the Company be liable in any such case for any such loss, claim, damage, liability or action to the extent that it arises out of or is based upon a
Violation which occurs in reliance upon and in conformity with written information furnished by such Holder, partner, member, legal counsel, accountant, officer, director, underwriter or controlling person of such Holder to the Company and stated to
be specifically for use in connection with such registration. 
 (b) To the extent permitted by law, each Holder will, if
Registrable Securities held by such Holder are included in the securities as to which such registration, qualification or compliance is being effected, on a several and not joint basis, indemnify and hold harmless the Company, each of its directors,
officers, legal counsel, and accountants, and each person, if any, who controls the Company within the meaning of the Securities Act, any underwriter and any 

  
 12.

 
other Holder selling securities under such registration statement or any of such other Holder’s partners, members, directors or officers or any person who controls such Holder, against any
losses, claims, damages or liabilities (joint or several) to which the Company or any such director, officer, legal counsel, accountant, controlling person, underwriter or other such Holder, or partner, member, director, officer or controlling
person of such other Holder may become subject under the Securities Act, the Exchange Act or other federal or state law, insofar as such losses, claims, damages or liabilities (or actions in respect thereto) arise out of or are based upon any of the
following statements: (i) any untrue statement or alleged untrue statement of a material fact contained in such registration statement or incorporated by reference therein, including any preliminary prospectus or final prospectus contained
therein or any amendments or supplements thereto, (ii) the omission or alleged omission to state therein a material fact required to be stated therein, or necessary to make the statements therein not misleading, or (iii) any violation or
alleged violation by the Company of the Securities Act (collectively, a “Holder Violation”), in each case to the extent (and only to the extent) that such Holder Violation is made in such registration statement, prospectus,
or other document incorporated by reference therein in reliance upon and in conformity with written information furnished by such Holder to the Company and stated to be specifically for use in connection with such registration; and each such Holder
will reimburse any legal or other expenses reasonably incurred by the Company or any such director, officer, legal counsel, accountant, controlling person, underwriter or other Holder, or partner, member, officer, director or controlling person of
such other Holder in connection with investigating or defending any such loss, claim, damage, liability or action; provided, however, that the indemnity agreement contained in this Section 2.9(b) shall not apply to amounts paid in
settlement of any such loss, claim, damage, liability or action if such settlement is effected without the consent of the Holder, which consent shall not be unreasonably withheld; provided further, that in no event shall any indemnity under
this Section 2.9 exceed the net proceeds from the offering received by such Holder. 
 (c) Promptly after receipt by
an indemnified party under this Section 2.9 of notice of the commencement of any action (including any governmental action), such indemnified party will, if a claim in respect thereof is to be made against any indemnifying party under this
Section 2.9, deliver to the indemnifying party a written notice of the commencement thereof and the indemnifying party shall have the right to participate in, and, to the extent the indemnifying party so desires, jointly with any other
indemnifying party similarly noticed, to assume the defense thereof with counsel mutually satisfactory to the parties; provided, however, that an indemnified party shall have the right to retain its own counsel, with the fees and expenses to
be paid by the indemnifying party, if representation of such indemnified party by the counsel retained by the indemnifying party would be inappropriate due to actual or potential differing interests between such indemnified party and any other party
represented by such counsel in such proceeding. The failure to deliver written notice to the indemnifying party within a reasonable time of the commencement of any such action, if materially prejudicial to its ability to defend such action, shall
relieve such indemnifying party of any liability to the indemnified party under this Section 2.9, but the omission to so deliver written notice to the indemnifying party will not relieve it of any liability that it may have to any indemnified
party otherwise than under this Section 2.9. Each indemnified party shall furnish such information regarding itself or the claim in question as an indemnifying party may reasonably request in writing and as shall be reasonably required in
connection with defense of such claim and litigation resulting therefrom. 

  
 13.

 (d) If the indemnification provided for in this Section 2.9 is held by a court
of competent jurisdiction to be unavailable to an indemnified party with respect to any losses, claims, damages or liabilities referred to herein, the indemnifying party, in lieu of indemnifying such indemnified party thereunder, shall to the extent
permitted by applicable law contribute to the amount paid or payable by such indemnified party as a result of such loss, claim, damage or liability in such proportion as is appropriate to reflect the relative fault of the indemnifying party on the
one hand and of the indemnified party on the other in connection with the Violation(s) or Holder Violation(s) that resulted in such loss, claim, damage or liability, as well as any other relevant equitable considerations. The relative fault of the
indemnifying party and of the indemnified party shall be determined by reference to, among other things, whether the untrue or alleged untrue statement of a material fact or the omission to state a material fact relates to information supplied by
the indemnifying party or by the indemnified party and the parties’ relative intent, knowledge, access to information and opportunity to correct or prevent such statement or omission; provided, that in no event shall any contribution by
a Holder hereunder exceed the net proceeds from the offering received by such Holder. 
 (e) The obligations of the
Company and Holders under this Section 2.9 shall survive completion of any offering of Registrable Securities in a registration statement and the termination of this Agreement. No indemnifying party, in the defense of any such claim or
litigation, shall, except with the consent of each indemnified party, consent to entry of any judgment or enter into any settlement which does not include as an unconditional term thereof the giving by the claimant or plaintiff to such indemnified
party of a release from all liability in respect to such claim or litigation. 
 2.10 Assignment of Registration Rights.
The rights to cause the Company to register Registrable Securities pursuant to this Section 2 may be assigned by a Holder to a transferee or assignee of Registrable Securities that (a) is a subsidiary, parent, general partner, limited
partner, retired partner, member, retired member or stockholder of a Holder that is a corporation, partnership or limited liability company, (b) is a Holder’s family member or trust for the benefit of an individual Holder or family member
or members, (c) acquires at least 120,000 (or, in the event that the transferor holds less than 120,000 Registrable Securities, all) of the Registrable Securities (as adjusted for any stock dividends, combinations, splits, recapitalizations and
the like after the date hereof) held by the transferor, (d) is a Holder of Registrable Securities prior to the transfer, or (e) is an entity affiliated by common control (or other related entity) with such Holder; provided, however,
(i) the transferor shall provide prior written notice to the Company of the name and address of such transferee or assignee and the securities with respect to which such registration rights are being assigned, (ii) such transferee shall
agree to be subject to all restrictions set forth in this Agreement, and (iii) such transfer or assignment of Registrable Securities is effected in accordance with Section 2.1 hereof, the Company’s Right of First Refusal and Co-Sale
Agreement dated as of even date herewith, the Company’s bylaws, and applicable securities laws. 
 2.11 Amendment of
Registration Rights. Any provision of this Section 2 may be amended and the observance thereof may be waived (either generally or in a particular instance and either retroactively or prospectively) with the written consent of the
Company and the Holders of at least a majority of the Registrable Securities then outstanding, not including the Founders Stock; provided, however, that if such amendment or waiver has the effect of affecting

  
 14.

 
the Founders Stock (a) in a manner different than securities issued to the Investors and (b) in a manner adverse to the interests of the holders of the Founders Stock, then such
amendment or waiver shall require the consent of the holder or holders of a majority of the Founders Stock. Any amendment or waiver effected in accordance with this Section 2.11 shall be binding upon each Holder, each future holder of all
Registrable Securities of each Holder and the Company. By acceptance of any benefits under this Section 2, Holders of Registrable Securities hereby agree to be bound by the provisions hereunder. 

2.12 Limitation on Subsequent Registration Rights. Other than as provided in Section 5.10, after the date of this Agreement,
the Company shall not enter into any agreement with any holder or prospective holder of any securities of the Company that would grant such holder rights to demand the registration of shares of the Company’s capital stock, or to include such
shares in a registration statement that would reduce the number of shares includable by the Holders or would otherwise grant registration rights on a parity with or senior to those granted to the Holders hereunder, other than the right to a Special
Registration Statement, without the prior written consent of the holders of at least a majority of the Registrable Securities then outstanding. 
 2.13 “Market Stand-Off” Agreement. Each Holder hereby agrees that such Holder shall not without the prior written consent of the Company and the representative of the
underwriters, sell, transfer, make any short sale of, grant any option for the purchase of, or enter into any hedging or similar transaction with the same economic effect as a sale with respect to, any Common Stock (or other securities) of the
Company held by such Holder (other than those included in the registration) for a period specified by the representative of the underwriters of Common Stock (or other securities) of the Company not to exceed 180 days following the effective date of
a registration statement of the Company filed under the Securities Act (the “Lock-Up Period”); provided that: 
 (i) such agreement shall apply only to a Qualified IPO; and 
 (ii)
all officers and directors of the Company and all holders of 1% or more of the Company’s securities (including any entities with which they are affiliated) enter into similar agreements. 

Each Holder agrees to execute and deliver such other agreements as may be reasonably requested by the Company or the underwriter that are consistent with
the Holder’s obligations under this Section 2.13 or that are necessary to give further effect thereto. In addition, if requested by the Company or the representative of the underwriters of Common Stock (or other securities) of the Company,
each Holder shall provide, within 10 days of such request, such information as may be required by the Company or such representative in connection with the completion of any public offering of the Company’s securities pursuant to a registration
statement filed under the Securities Act. The obligations described in this Section 2.13 shall not apply to a Special Registration Statement. The Company may impose stop-transfer instructions with respect to the shares of Common Stock (or other
securities) subject to the foregoing restriction until the end of such specified period. Each Holder agrees that any transferee of any shares of Registrable Securities shall be bound by this Section 2.13. The underwriters of the Company’s
stock are 

  
 15.

 
intended third party beneficiaries of this Section 2.13 and shall have the right, power and authority to enforce the provisions hereof as though they were a party hereto. 

Notwithstanding the foregoing, for the purpose of compliance with NASD Rule 2711(f)(4), if (a) during the last 17 days of the
initial Lock-Up Period, the Company releases earnings results or material news or a material event relating to the Company occurs, or (b) prior to the expiration of the initial Lock-Up Period, the Company announces that it will release earnings
results during the 16-day period beginning on the last day of the initial Lock-Up Period, then in each case, each Holder hereby consents to an extension to the Lock-Up Period until the expiration of the 18-day period beginning on the date of release
of the earnings results or the occurrence of the material news or material event, as applicable, unless such extension is waived in writing. 
 2.14 Rule 144 Reporting. With a view to making available to the Holders the benefits of certain rules and regulations of the SEC which may permit the sale of the Registrable Securities to the
public without registration, the Company agrees to use its best efforts to: 
 (a) Make and keep public information
available, as those terms are understood and defined in SEC Rule 144 or any similar or analogous rule promulgated under the Securities Act, at all times from and after the effective date of the Initial Offering; 

(b) File with the SEC, in a timely manner, all reports and other documents required of the Company under the Exchange Act at any
time after it has become subject to such reporting requirements; and 
 (c) So long as a Holder owns any Registrable
Securities, furnish to such Holder forthwith upon request: a written statement by the Company as to its compliance with the reporting requirements of SEC Rule 144, and of the Exchange Act (at any time after it has become subject to such reporting
requirements); a copy of the most recent annual or quarterly report of the Company filed with the Commission; and such other reports and documents as a Holder may reasonably request in connection with availing itself of any rule or regulation of the
SEC allowing it to sell any such securities without registration. 
  

	3.	COVENANTS OF THE COMPANY. 

3.1 Basic Financial Information and Reporting. 
 (a) So long as an Investor (together with its affiliates) holds not less than 120,000 shares of Registrable Securities (as adjusted for any stock dividends, combinations, splits, recapitalizations
and the like after the date hereof) (a “Major Investor”), as soon as practicable after the end of each quarter, and in any event within 45 days thereafter, the Company will furnish to each Major Investor an unaudited balance
sheet of the Company as of the end of each such quarter, unaudited statements of income and cash flows of the Company for such quarter, including a comparison to budget figures for such period, prepared in accordance with generally accepted
accounting principles consistently applied (except as noted therein), with the exception that no notes need be attached to such statements and year-end audit adjustments 

  
 16.

 
may not have been made, and an updated capitalization chart of the Company (in such form as may be approved by the Board). 

(b) So long as any Shares remain outstanding, the Company will furnish: 

(i) to each Major Investor, at least 30 days prior to the beginning of each fiscal year, an annual budget for such fiscal year as
approved by the Board of Directors of the Company (and as soon as available, any subsequent written revisions thereto); and 

(ii) to each Investor as soon as practicable after the end of each fiscal year of the Company, and in any event within 270 days
thereafter, an audited balance sheet of the Company as of the end of such fiscal year, audited statements of income and cash flows of the Company for such year, including a comparison to budget figures for such year, prepared in accordance with
generally accepted accounting principles consistently applied and certified by a firm of independent public accountants of recognized national standing selected by the Board of Directors of the Company, and an updated capitalization chart of the
Company (in such form as may be approved by the Board). 
 3.2 Inspection Rights. Each Major Investor shall have the
right to visit and inspect any of the properties of the Company or any of its subsidiaries, and to discuss the affairs, finances and accounts of the Company or any of its subsidiaries with its executive officers, and to review such information as is
reasonably requested all at such reasonable times and as often as may be reasonably requested; provided, however, that the Company shall not be obligated under this Section 3.2 with respect to any Major Investor whom the Board determines
in good faith to be a competitor of the Company or with respect to information which the Board of Directors determines in good faith is confidential or attorney-client privileged and should not, therefore, be disclosed. 

3.3 Confidentiality. Each Investor agrees to keep confidential any information furnished to such Investor that the Company
identifies, or which would otherwise reasonably appear, as being confidential or proprietary, except that such Investor may disclose such proprietary or confidential information (i) to any partner, member, subsidiary, parent or affiliate of
such Investor for the purpose of evaluating its investment in the Company as long as such partner, member, subsidiary, parent or affiliate is advised of and agrees or has agreed to be bound by the confidentiality provisions of this Section 3.3
or comparable restrictions; (ii) at such time as it enters the public domain through no fault of such Investor; (iii) that is communicated to it free of any obligation of confidentiality; or (iv) that is developed by Investor or its
agents independently of and without reference to any confidential information communicated by the Company. 
 3.4 Reservation
of Common Stock. The Company will at all times reserve and keep available, solely for issuance and delivery upon the conversion of the Series A Stock, Series B Stock and Series C Stock, all Common Stock issuable from time to time upon such
conversion. 
 3.5 Stock Vesting; Repurchase. Unless otherwise approved by the Board of Directors or duly authorized
committee thereof, all stock options and other stock equivalents issued after the date of this Agreement to employees, directors, consultants and other service 

  
 17.

 
providers shall be subject to vesting over a four-year period, as follows: (a) 25% of such stock shall vest at the end of the first 12 months of service, and (b) 75% of such stock shall
vest in equal monthly installments over the remaining three years. Any agreement regarding the acceleration of vesting of any stock options and other stock equivalents must be approved by a majority of disinterested members of the Board of Directors
or duly authorized committee thereof. The Company shall maintain a right to repurchase in the applicable documents relating to any stock options and other stock equivalents, at a price equal to the original issue price, any unvested shares issued
after the date of this Agreement to employees, directors, consultants and other service providers in the event that such person’s employment with the Company is terminated or such person otherwise ceases to perform services for the Company.

 3.6 Proprietary Information and Inventions Agreement. The Company shall require all employees and consultants to
execute and deliver a proprietary information and invention assignment agreement in the form attached to the Purchase Agreement as Exhibit H. 
 3.7 Director and Officer Insurance. The Company will take all reasonable actions necessary to maintain director and officer liability insurance in the amount of at least $1,000,000 and pay all
premiums and other amounts due with respect to such policy. Notwithstanding the foregoing, the Company shall not be required to maintain such insurance if the Board of Directors determines it would not be in the best interests of the Company.

 3.8 Qualified Small Business. The Company will use reasonable efforts to comply with the reporting and recordkeeping
requirements of Section 1202 of the Internal Revenue Code of 1986, as amended (the “Code”), any regulations promulgated thereunder and any similar state laws and regulations. The Company further covenants to submit to
its stockholders and to state and federal taxation authorities such forms and filings as may be required to document such compliance, including the California Franchise Tax Board Form 3565, Small Business Stock Questionnaire, with its franchise or
income tax return for the current income year. 
 3.9 Key Person Insurance. Promptly after the date hereof, the Company
and the Investors will take all reasonable actions necessary to obtain a term life insurance policy in the amount of approximately $4,000,000 on the life of Pamela G. Marrone with the Company as the sole beneficiary under the policy.
Thereafter, the Company will pay all premiums and other amounts due with respect to such policy and will use its reasonable efforts to maintain such policy in full force and effect. 

3.10 Stock Option Plan. The Company agrees that on or after the date hereof it shall not, without the consent of the Board of
Directors or duly authorized committee thereof grant any shares, awards, options, warrants, purchase rights or other securities under (or amend, modify or alter any of the foregoing that are outstanding on the date hereof), or amend, modify or alter
the Company’s stock option plan, or approve or adopt any other stock option plan, stock incentive plan, employee stock benefit plan, employee stock bonus plan or other equity compensation arrangement. 

3.11 Observer Rights. 

  
 18.

 (a) If at any time (i) CGI Opportunity Fund II, L.P.
(“Contrarian”) has not elected a designee to the Board of Directors and (ii) Contrarian is the owner of at least 970,000 Shares, Contrarian shall be entitled to appoint one representative to attend each meeting
(including telephonic meetings) of the Board of Directors in a nonvoting observer capacity (the “Contrarian Board Observer”). The Contrarian Board Observer shall be entitled to receive notice of each such meeting in the same
form and manner as is given to the members of the Board of Directors (the “Directors”) and the same materials as and when provided to the Directors. The Board of Directors shall not conduct any material business by written
consent without giving notice (which may be after the fact) to the Contrarian Board Observer. The foregoing notwithstanding, the Contrarian Board Observer may be excluded from any meeting or receiving any information to the extent necessary or
appropriate to protect any confidential matters discussed therein, as necessary or appropriate to protect the Company’s attorney/client privilege or in the event that the Board of Directors reasonably determines in good faith that the
Contrarian Board Observer has a conflicting interest. 
 (b) If at any time (i) CVV Partners L.P.
(“CVVP”) has not elected a designee to the Board of Directors and (ii) CVVP is the owner of at least 120,000 Shares, CVVP shall be entitled to appoint one representative to attend each meeting (including telephonic
meetings) of the Board of Directors in a nonvoting observer capacity (the “CVVP Board Observer”). The CVVP Board Observer shall be entitled to receive notice of each such meeting in the same form and manner as is given to the
Directors and the same materials as and when provided to the Directors. The Board of Directors shall not conduct any material business by written consent without giving notice (which may be after the fact) to the CVVP Board Observer. The foregoing
notwithstanding, the CVVP Board Observer may be excluded from any meeting or receiving any information to the extent necessary or appropriate to protect any confidential matters discussed therein, as necessary or appropriate to protect the
Company’s attorney/client privilege or in the event that the Board of Directors reasonably determines in good faith that the CVVP Board Observer has a conflicting interest. 

(c) If at any time (i) One Earth Capital, LLC (“One Earth”) has not elected a designee to the Board
of Directors and (ii) One Earth is the owner of at least 970,000 Shares, One Earth shall be entitled to appoint one representative to attend each meeting (including telephonic meetings) of the Board of Directors in a nonvoting observer capacity
(the “One Earth Board Observer”). The One Earth Board Observer shall be entitled to receive notice of each such meeting in the same form and manner as is given to the Directors and the same materials as and when provided to
the Directors. The Board of Directors shall not conduct any material business by written consent without giving notice (which may be after the fact) to the One Earth Board Observer. The foregoing notwithstanding, the One Earth Board Observer may be
excluded from any meeting or receiving any information to the extent necessary or appropriate to protect any confidential matters discussed therein, as necessary or appropriate to protect the Company’s attorney/client privilege or in the event
that the Board of Directors reasonably determines in good faith that the One Earth Board Observer has a conflicting interest. 

(d) If at any time (i) Stuart Mill Venture Partners, L.P. (“SMVP”) has not elected a designee to the Board
of Directors and (ii) SMVP is the owner of at least 970,000 Shares, SMVP shall be entitled to appoint one representative to attend each meeting (including telephonic meetings) of the Board of Directors in a nonvoting observer capacity (the
“SMVP 

  
 19.

 
Board Observer”). The SMVP Board Observer shall be entitled to receive notice of each such meeting in the same form and manner as is given to the members of the Board of
Directors (the “Directors”) and the same materials as and when provided to the Directors. The Board of Directors shall not conduct any material business by written consent without giving notice (which may be after the fact)
to the SMVP Board Observer. The foregoing notwithstanding, the SMVP Board Observer may be excluded from any meeting or receiving any information to the extent necessary or appropriate to protect any confidential matters discussed therein, as
necessary or appropriate to protect the Company’s attorney/client privilege or in the event that the Board of Directors reasonably determines in good faith that the SMVP Board Observer has a conflicting interest. 

3.12 Restrictive Covenants. The vote or written consent of the Board of Directors or a committee thereof (in either case,
including the approval of at least two of the Series C Director or the Series B Directors, as defined in the Restated Charter) shall be required for the Company to (a) enter into any transaction between the Company, on the one hand, and in each
case immediately prior to such transaction any person or entity that controls, is controlled by or is under common control with the Company, or any employee, officer, director or 2% stockholder (or affiliate or immediate family member thereof) of
the Company, on the other hand, other than (i) transactions involving employment, compensation, benefits or similar incidents of employment or (ii) transactions involving the financing of the Company that are subject to Section 4 of
this Agreement or the waiver of rights thereunder or are excluded therefrom pursuant to Section 4.6 of this Agreement; or (b) adopt, amend or waive any provision with respect to any director only benefit plan, director only stock option
plan, director only stock bonus plan or director only stock purchase plan. 
 3.13 Termination of Covenants. All
covenants of the Company contained in Section 3 of this Agreement (other than the provisions of Section 3.3 and Section 3.8) shall terminate upon the earlier of (i) the closing of the Initial Offering, (ii) the closing of an
Acquisition or Asset Transfer or (iii) such time as the Company becomes subject to the reporting provisions of the Exchange Act. 
  

	4.	RIGHTS OF FIRST REFUSAL. 

4.1 Subsequent Offerings. Subject to applicable securities laws and the remainder of this Section 4, each Investor shall have
a right of first refusal to purchase its pro rata share of all Equity Securities, as defined below, that the Company may, from time to time, propose to sell and issue after the date of this Agreement, other than the Equity Securities excluded
by Section 4.6 hereof. Each Investor’s pro rata share is equal to the ratio of (a) the number of shares of the Company’s Common Stock (including all shares of Common Stock issuable or issued upon conversion of the Shares
then held by such Investor or upon the exercise of outstanding warrants or options then held by such Investor) of which such Investor is deemed to be a holder immediately prior to the issuance of such Equity Securities to (b) the total number
of shares of the Company’s then outstanding Common Stock (including all shares of Common Stock issued or issuable upon conversion of the then outstanding Shares or upon the exercise of any outstanding warrants or options) immediately prior to
the issuance of such Equity Securities. The term “Equity Securities” shall mean (i) any Common Stock, Preferred Stock or other equity security of the Company or (ii) any security convertible into or exercisable for,
with or without 

  
 20.

 
consideration, any Common Stock, Preferred Stock or other equity security of the Company (including any option to purchase such a convertible security). 

4.2 Exercise of Rights. If the Company proposes to issue any Equity Securities, it shall give each Investor written notice of its
intention, describing the Equity Securities, the price and the terms and conditions upon which the Company proposes to issue the same. Each Investor shall have 15 days from the giving of such notice to agree to purchase all or a portion of its
pro rata share of the Equity Securities for the price and upon the terms and conditions specified in the notice by giving written notice to the Company and stating therein the quantity of Equity Securities to be purchased. Notwithstanding the
foregoing, the Company shall not be required to offer or sell such Equity Securities to any Investor who would cause the Company to be in violation of applicable federal securities laws by virtue of such offer or sale. 

4.3 Issuance of Equity Securities to Other Persons. If not all of the Investors elect to purchase their full pro rata share
of the Equity Securities, then the Company shall promptly notify in writing the Investors who do so elect (“Fully-Exercising Investors”) and shall offer such Fully-Exercising Investors the right to acquire such unsubscribed
shares on a pro rata basis. Each such Fully-Exercising Investor shall have 10 days after receipt of such notice to notify the Company of its election to purchase all or a portion of its pro rata share of the unsubscribed shares. For
purposes of the preceding sentence, each Fully-Exercising Investor’s pro rata share shall be as determined pursuant to Section 4.1, except that clause (b) thereof shall be equal to the total number of shares of the
Company’s then outstanding Common Stock (including all shares of Common Stock issued or issuable upon conversion of the then outstanding Shares or upon the exercise of any outstanding warrants or options) of which the Fully-Exercising Investors
are deemed to be the holders immediately prior to the issuance of the Equity Securities. The Company shall have 90 days thereafter to sell the Equity Securities in respect of which the Investors’ rights were not exercised, at the same price and
upon other terms and conditions not materially more favorable to the purchasers thereof than specified in the Company’s notice to the Investors pursuant to Section 4.2 hereof. If the Company does not sell such Equity Securities within such
90 day period, the Company shall not thereafter issue or sell such Equity Securities without first offering such Equity Securities to the Investors in the manner provided above. 

4.4 Termination and Waiver of Rights of First Refusal. The rights of first refusal set forth in this Section 4 shall not
apply to, and shall terminate upon the earliest of (i) the closing of a Qualified IPO or (ii) the closing of an Asset Transfer or Acquisition. 
 4.5 Transfer of Rights of First Refusal. The rights of first refusal of each Investor set forth in this Section 4 may be transferred to the same parties, and subject to the same restrictions,
as any transfer of registration rights pursuant to Section 2.10. 
 4.6 Excluded Securities. The rights of first
refusal set forth in this Section 4 shall have no application to any of the following Equity Securities: 
 (a) The
Shares and the shares of Common Stock issued upon conversion of, or as a dividend or distribution of, the Shares; 

  
 21.

 (b) shares of Common Stock and/or options, warrants or other Common Stock purchase
rights, and the Common Stock issued pursuant to such options, warrants or other rights (as adjusted for any stock dividends, combinations, splits, recapitalizations and the like after the date hereof) issued after the date of this Agreement to
employees, officers or directors of, or consultants or advisors to, the Company or any subsidiary pursuant to stock purchase or stock option plans or other arrangements that are approved by the Board of Directors and, if applicable, the holders of
Preferred Stock as set forth in the Restated Charter; 
 (c) any Equity Securities issued or issuable pursuant to any
options, warrants, convertible securities or other rights outstanding as of the date of this Agreement; 
 (d) any Equity
Securities issued pursuant to any options, warrants, convertible securities or other rights issued after the date of this Agreement, so long as the rights of first refusal set forth in this Section 4 were complied with or were inapplicable
pursuant to any provision of this Section 4.6 with respect to the initial issuance by the Company of such options, warrants, convertible securities or other rights; 
 (e) any Equity Securities issued for consideration other than cash pursuant to a merger, purchase of substantially all of the assets, consolidation, acquisition, strategic alliance, or similar
business combination transaction; provided that the issuance of shares therein has been approved by the Board of Directors and, if applicable, the holders of Preferred Stock as set forth in the Restated Charter; 

(f) any Equity Securities issued in connection with any stock split, stock dividend or recapitalization by the Company;
provided that the issuance of shares therein has been approved by the Board of Directors; 
 (g) any Equity
Securities issued or issuable pursuant to any options, warrants, convertible securities or other rights issued in connection with any equipment loan or leasing arrangement, credit agreements, real property leasing arrangement, or debt financing from
a bank or similar financial institution; provided that the issuance of shares therein has been approved by the Board of Directors; 
 (h) any Equity Securities issued in a Qualified IPO; 
 (i) any
Equity Securities issued pursuant to the Purchase Agreement; 
 (j) any Equity Securities issued or issuable pursuant to
any options, warrants, convertible securities or other rights issued to third-party service providers in exchange for or as partial consideration for services rendered to the Company; provided that the issuance of shares therein has been
approved by the Board of Directors; and 
 (k) any Equity Securities issued or issuable pursuant to any options,
warrants, convertible securities or other rights issued in connection with strategic transactions involving the Company and other entities, including (i) joint ventures, manufacturing, marketing, customer, vendor or distribution arrangements or
(ii) collaboration, technology transfer or development arrangements, including technology licenses; provided that the issuance of shares therein has been approved by the Board of Directors. 

  
 22.

	5.	MISCELLANEOUS. 

 5.1 Governing Law. This Agreement shall be governed by and construed under the laws of the State of Delaware in all respects as such laws are applied to agreements among Delaware residents entered
into and to be performed entirely within Delaware. 
 5.2 Successors and Assigns. Except as provided below, this
Agreement, and any and all rights, duties and obligations hereunder, shall not be assigned, transferred, delegated or sublicensed by any Investor or Holder without the prior written consent of the Company and any attempt by an Investor or Holder
without such permission to assign, transfer, delegate or sublicense any rights, duties or obligations that arise under this Agreement shall be void. Subject to Sections 2.10 and 4.5 hereof, any Investor or Holder may assign, transfer, delegate
or sublicense any and all of its rights, duties and obligations hereunder to any transferee or assignee of Shares held by such Investor or Holder. Subject to the foregoing and except as otherwise provided herein, the provisions of this Agreement
shall inure to the benefit of, and be binding upon, the parties hereto and their respective successors, assigns, heirs, executors and administrators. 
 5.3 Entire Agreement. This Agreement, the Exhibits hereto, the Purchase Agreement and the other documents delivered pursuant thereto constitute the full and entire understanding and agreement
between the parties with regard to the subjects hereof and thereof and no party shall be liable or bound to any other in any manner by any oral or written representations, warranties, covenants and agreements except as specifically set forth herein
and therein. Each party expressly represents and warrants that it is not relying on any oral or written representations, warranties, covenants or agreements outside of this Agreement and the Related Agreements (as defined in the Purchase Agreement).
The Company, the Founders and the Investors who are parties to the Prior IR Agreement agree that the Prior IR Agreement is hereby amended and restated and shall be superseded and replaced in its entirety by this Agreement and that the Prior IR
Agreement shall be of no further force or effect. 
 5.4 Severability. In the event one or more of the provisions of this
Agreement should, for any reason, be held to be invalid, illegal or unenforceable in any respect, such invalidity, illegality, or unenforceability shall not affect any other provisions of this Agreement, and this Agreement shall be construed as if
such invalid, illegal or unenforceable provision had never been contained herein. 
 5.5 Amendment and Waiver.

 (a) Except as otherwise expressly provided, this Agreement may be amended or modified and the observance thereof
may be waived (either generally or in a particular instance and either retroactively or prospectively) upon the written consent of (i) the Company and (ii) the holders of at least a majority of the then-outstanding Registrable Securities
not including the Founders Stock; provided, however, that if such amendment or waiver has the effect of affecting the Founders Stock (i) in a manner different than securities issued to the Investors and (ii) in a manner adverse to the
interests of the holders of the Founders Stock, then such amendment or waiver shall require the consent of the holder or holders of a majority of the Founders Stock; provided, further, that the provisions regarding the Contrarian Board Observer

  
 23.

 
in Section 3.11(a) of this Agreement shall not be amended or waived without the written consent of Contrarian; provided, further, that the provisions regarding the CVVP Board Observer in
Section 3.11(b) of this Agreement shall not be amended or waived without the written consent of CVVP; provided, further, that the provisions regarding the One Earth Board Observer in Section 3.11(c) of this Agreement shall not be amended
or waived without the written consent of One Earth; and provided, further, that the provisions regarding the SMVP Board Observer in Section 3.11(d) of this Agreement shall not be amended or waived without the written consent of SMVP.

 (b) For the purposes of determining the number of Holders or Investors entitled to vote or exercise any rights
hereunder, the Company shall be entitled to rely solely on the list of record holders of its stock as maintained by or on behalf of the Company. 
 Except as otherwise expressly provided herein, any such amendment, waiver, discharge or termination effected in accordance with this Section 5.5 shall be binding upon each Holder and each future
holder of all Registrable Securities of Holder, whether or not such party entered into or approved such amendment, waiver, discharge or termination. Each Holder acknowledges that by the operation of this paragraph, the holders of at least a majority
of the Registrable Securities then outstanding will have the right and power to diminish or eliminate the rights of such Holder under this Agreement except to the extent otherwise expressly provided in this Agreement. 

5.6 Delays or Omissions. It is agreed that no delay or omission to exercise any right, power, or remedy accruing to any party,
upon any breach, default or noncompliance by another party under this Agreement shall impair any such right, power, or remedy, nor shall it be construed to be a waiver of any such breach, default or noncompliance, or any acquiescence therein, or of
any similar breach, default or noncompliance thereafter occurring. It is further agreed that any waiver, permit, consent, or approval of any kind or character on any party’s part of any breach, default or noncompliance under the Agreement or
any waiver on such party’s part of any provisions or conditions of this Agreement must be in writing and shall be effective only to the extent specifically set forth in such writing. All remedies, either under this Agreement, by law, or
otherwise afforded to any party, shall be cumulative and not alternative. 
 5.7 Notices. All notices required or
permitted hereunder shall be in writing and shall be deemed effectively given: (a) upon personal delivery to the party to be notified, (b) when sent by confirmed electronic mail or facsimile if sent during normal business hours of the
recipient; if not, then on the next business day, (c) three days after having been sent by registered or certified mail, return receipt requested, postage prepaid, or (d) one day after deposit with a nationally recognized overnight
courier, specifying next day delivery, with written verification of receipt. All notices shall be sent to the party to be notified (and, if to the Company, with a copy to Clifford S. Robbins, Esq., GCA Law Partners LLP, 1891 Landings Drive, Mountain
View, California 94043, facsimile: (650) 428-3901) at the address as set forth on the signature pages hereof or Exhibit A, Exhibit B or Exhibit C hereto or at such other address or electronic mail address as such party may
designate by two days advance written notice to the other parties hereto. 
 5.8 Attorneys’ Fees. In the event that
any suit or action is instituted under or in relation to this Agreement, including without limitation to enforce any provision in this Agreement, the prevailing party in such dispute shall be entitled to recover from the losing party

  
 24.

 
all fees, costs and expenses of enforcing any right of such prevailing party under or with respect to this Agreement, including without limitation, such reasonable fees and expenses of attorneys
and accountants, which shall include, without limitation, all reasonable fees, costs and expenses of appeals. 
 5.9 Titles
and Subtitles. The titles of the sections and subsections of this Agreement are for convenience of reference only and are not to be considered in construing this Agreement. 

5.10 Additional Investors. Notwithstanding anything to the contrary contained herein, if the Company shall issue additional shares
of its Series C Stock pursuant to the Purchase Agreement, any purchaser of such shares of Series C Stock shall become a party to this Agreement by executing and delivering an additional counterpart signature page to this Agreement and shall be
deemed an “Investor,” a “Holder” and a party hereunder. Notwithstanding anything to the contrary contained herein, if the Company shall issue Equity Securities described in Section 4.6 (e), (g),
(i), (j) or (k) of this Agreement, any purchaser of such Equity Securities may become a party to this Agreement by executing and delivering an additional counterpart signature page to this Agreement and shall be deemed an
“Investor,” a “Holder” and a party hereunder. 
 5.11 Counterparts; Facsimile
Signatures. This Agreement may be executed in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument. This Agreement may be executed and delivered by facsimile
and upon such delivery the facsimile signature will be deemed to have the same effect as if the original signature had been delivered to the other party. 
 5.12 Aggregation of Stock. All shares of Registrable Securities held or acquired by affiliated entities or persons or persons or entities under common management or control shall be aggregated
together for the purpose of determining the availability of any rights under this Agreement. 
 5.13 Pronouns. All
pronouns contained herein, and any variations thereof, shall be deemed to refer to the masculine, feminine or neutral, singular or plural, as to the identity of the parties hereto may require. 

5.14 Waiver. Each Investor hereby waives all rights of first refusal under the Prior IR Agreement, including any notice rights
pertaining thereto, to purchase the shares of Series C Stock being issued and sold pursuant to the Purchase Agreement (and any shares of Common Stock issuable upon conversion thereof). Each Investor hereby waives the limitation on granting
subsequent registration rights pursuant to Section 2.12 of the Prior IR Agreement. 
 [Remainder of page intentionally left
blank] 

  
 25.

 IN WITNESS WHEREOF, the parties hereto
have executed this SECOND AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT as of the date set forth in the first paragraph
hereof. 
  

									
	COMPANY:	 		 	INVESTORS:
			
	 MARRONE BIO INNOVATIONS, INC.,

a Delaware corporation
	 		 	PAMELA G. MARRONE & MICHAEL J. ROGERS
					
	By:	 	/s/ Pam Marrone	 		 	By:	 	/s/ Pamela G. Marrone & Michael J. Rogers
		 	Pam Marrone	 		 	Name:	 	 
		 	President	 		 	Title:	 	 

     2121 Second Street, Suite B-107 

    Davis, CA 95618 
     Fax No.: (530) 750-2808 
  

	
	FOUNDERS:
	
	/s/ Pamela G. Marrone
	Pamela G. Marrone

  

	
	/s/ Julie I. Morris
	Julie I. Morris

  

	
	/s/ Richard C. Dorf
	Richard C. Dorf

  

	
	/s/ Richard E. Rominger
	Richard E. Rominger

 [SIGNATURE PAGE TO AMENDED AND
RESTATED INVESTOR RIGHTS AGREEMENT] 

 IN WITNESS
WHEREOF, the parties hereto have executed this SECOND AMENDED AND RESTATED INVESTOR RIGHTS
AGREEMENT as of the date set forth in the first paragraph hereof. 
  

									
		 		 	INVESTORS:
			
		 		 	JULIE IONE MORRIS 2001 TRUST
					
		 		 		 	By:	 	 /s/ Julie I. Morris

		 		 		 	Name: Julie I. Morris
		 		 		 	Title: Trustee

 [SIGNATURE PAGE TO AMENDED AND
RESTATED INVESTOR RIGHTS AGREEMENT] 

 IN WITNESS
WHEREOF, the parties hereto have executed this SECOND AMENDED AND RESTATED INVESTOR RIGHTS
AGREEMENT as of the date set forth in the first paragraph hereof. 
  

			
	INVESTORS:
	
	RICHARD & MARY ROMINGER COMMUNITY PROPERTY TRUST
		
	By:	 	/s/ Richard E. Rominger & Mary Evelyne Rominger
	Name: Richard E. Rominger & Mary Evelyne Rominger
	Title: Trustees

 [SIGNATURE PAGE TO AMENDED
AND RESTATED INVESTOR RIGHTS AGREEMENT] 

 IN WITNESS
WHEREOF, the parties hereto have executed this SECOND AMENDED AND RESTATED INVESTOR RIGHTS
AGREEMENT as of the date set forth in the first paragraph hereof. 
  

			
	INVESTORS:
	
	AKERS WATERMAN TRUST
		
	By:	 	/s/ Roger Akers
	Name: Roger Akers
	Title: Trustees

 [SIGNATURE PAGE TO AMENDED
AND RESTATED INVESTOR RIGHTS AGREEMENT] 

 IN WITNESS
WHEREOF, the parties hereto have executed this SECOND AMENDED AND RESTATED INVESTOR RIGHTS
AGREEMENT as of the date set forth in the first paragraph hereof. 
  

			
	INVESTORS:
	
	CALVERT SOCIAL INVESTMENT FUND EQUITY PORTFOLIO
		
	By:	 	/s/ Susan Walker Bender
	Name: Susan Walker Bender
	Title: Asst, Secretary and Authorized Signer

 [SIGNATURE PAGE TO AMENDED
AND RESTATED INVESTOR RIGHTS AGREEMENT] 

 IN WITNESS
WHEREOF, the parties hereto have executed this SECOND AMENDED AND RESTATED INVESTOR RIGHTS
AGREEMENT as of the date set forth in the first paragraph hereof. 
  

			
	INVESTORS:
	
	CAMILLE CHAN TRUST DATED MARCH 28, 2002
		
	By:	 	 /s/ Camille Chan

	Name: Camille Chan
	Title: Investor

 [SIGNATURE PAGE TO AMENDED
AND RESTATED INVESTOR RIGHTS AGREEMENT] 

 IN WITNESS
WHEREOF, the parties hereto have executed this SECOND AMENDED AND RESTATED INVESTOR RIGHTS
AGREEMENT as of the date set forth in the first paragraph hereof. 
  

			
	INVESTORS:
	
	CGI OPPORTUNITY FUND II, L.P.
		
	By:	 	 /s/ Timothy T. Fogarty

	Name: Timothy T. Fogarty
	Title: Partner

 [SIGNATURE PAGE TO AMENDED
AND RESTATED INVESTOR RIGHTS AGREEMENT] 

 IN WITNESS
WHEREOF, the parties hereto have executed this SECOND AMENDED AND RESTATED INVESTOR RIGHTS
AGREEMENT as of the date set forth in the first paragraph hereof. 
  

			
	INVESTORS:
	
	 CPV PARTNER PLEDGE FUND, LP (A2)

CPV PARTNER PLEDGE FUND, LP (A5)

		
	By:	 	 /s/ Sean Schickedanz

	Name: Sean Schickedanz
	Title: General Partner

 [SIGNATURE PAGE TO AMENDED
AND RESTATED INVESTOR RIGHTS AGREEMENT] 

 IN WITNESS
WHEREOF, the parties hereto have executed this SECOND AMENDED AND RESTATED INVESTOR RIGHTS
AGREEMENT as of the date set forth in the first paragraph hereof. 
  

			
	INVESTORS:
	
	 CPV PARTNER PLEDGE FUND, LP

SERIES A-8

		
	By:	 	 /s/ Sean P. Schickedanz

	Name: Sean P. Schickedanz
	Title: General Partner

 [SIGNATURE PAGE TO AMENDED
AND RESTATED INVESTOR RIGHTS AGREEMENT] 

 IN WITNESS
WHEREOF, the parties hereto have executed this SECOND AMENDED AND RESTATED INVESTOR RIGHTS
AGREEMENT as of the date set forth in the first paragraph hereof. 
  

			
	INVESTORS:
	
	 CHARLES W. CUNNINGHAM

DEBORAH L.DUNHAM

		
	By:	 	 /s/ Charles W. Cunningham

	Name:	 	Charles W. Cunningham
	Title:	 	 
		 	

 [SIGNATURE PAGE TO AMENDED
AND RESTATED INVESTOR RIGHTS AGREEMENT] 

 IN WITNESS
WHEREOF, the parties hereto have executed this SECOND AMENDED AND RESTATED INVESTOR RIGHTS
AGREEMENT as of the date set forth in the first paragraph hereof. 
  

			
	INVESTORS:
	
	CVV PARTNERS L.P.
		
	By:	 	 /s/ Peter Bernardoni

	Name:	 	Peter Bernardoni
	Title:	 	Manager

 [SIGNATURE PAGE TO AMENDED
AND RESTATED INVESTOR RIGHTS AGREEMENT] 

 IN WITNESS
WHEREOF, the parties hereto have executed this SECOND AMENDED AND RESTATED INVESTOR RIGHTS
AGREEMENT as of the date set forth in the first paragraph hereof. 
  

			
	INVESTORS:
	
	DAVIS MONTESSORI SCHOOL SERVICES
		
	By:	 	 /s/ John M. Hillis

	Name:	 	John M. Hillis
	Title:	 	Owner

 [SIGNATURE PAGE TO AMENDED
AND RESTATED INVESTOR RIGHTS AGREEMENT] 

 IN WITNESS
WHEREOF, the parties hereto have executed this SECOND AMENDED AND RESTATED INVESTOR RIGHTS
AGREEMENT as of the date set forth in the first paragraph hereof. 
  

			
	INVESTORS:
	
	FARMAN REVOCABLE TRUST
		
	By:	 	/s/ Charles S. Farman
	Name:	 	Charles S. Farman
	Title:	 	Trustee

 [SIGNATURE PAGE TO AMENDED
AND RESTATED INVESTOR RIGHTS AGREEMENT] 

 IN WITNESS
WHEREOF, the parties hereto have executed this SECOND AMENDED AND RESTATED INVESTOR RIGHTS
AGREEMENT as of the date set forth in the first paragraph hereof. 
  

			
	INVESTORS:
	
	 
		
	By:	 	/s/ Daniel S. Koellen
	Name:	 	Daniel S. Koellen
	Title:	 	Investor

 [SIGNATURE PAGE TO AMENDED
AND RESTATED INVESTOR RIGHTS AGREEMENT] 

 IN WITNESS WHEREOF, the
parties hereto have executed this SECOND AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT as of the date set forth in the
first paragraph hereof. 
  

			
	INVESTORS:
	
	ETHAN A. LERNER
		
	By:	 	/s/ Ethan A. Lerner
	Name:	 	Ethan A. Lerner
	Title:	 	Investor

 [SIGNATURE PAGE TO AMENDED
AND RESTATED INVESTOR RIGHTS AGREEMENT] 

 IN WITNESS
WHEREOF, the parties hereto have executed this SECOND AMENDED AND RESTATED INVESTOR RIGHTS
AGREEMENT as of the date set forth in the first paragraph hereof. 
  

			
	INVESTORS:
	
	 
		
	By:	 	/s/ Florence H. Marrone
	Name:	 	Florence H. Marrone
	Title:	 	 

 [SIGNATURE PAGE TO AMENDED
AND RESTATED INVESTOR RIGHTS AGREEMENT] 

 IN WITNESS
WHEREOF, the parties hereto have executed this SECOND AMENDED AND RESTATED INVESTOR RIGHTS
AGREEMENT as of the date set forth in the first paragraph hereof. 
  

			
	INVESTORS:
	
	 
		
	By:	 	/s/ Roger E. Merriam
	Name:	 	Roger E. Merriam
	Title:	 	Investor

 [SIGNATURE PAGE TO AMENDED
AND RESTATED INVESTOR RIGHTS AGREEMENT] 

 IN WITNESS
WHEREOF, the parties hereto have executed this SECOND AMENDED AND RESTATED INVESTOR RIGHTS
AGREEMENT as of the date set forth in the first paragraph hereof. 
  

			
		 	 Jeffrey M. Nash and Kathleen L. Nash
 Trustees of the Nash Family Trust dated
 3/18/80, as Amended

		
	By:	 	 /s/ Jeffrey M. Nash 

	Name: Jeffrey M. Nash
	Title: Co-Trustee

 [SIGNATURE PAGE TO AMENDED
AND RESTATED INVESTOR RIGHTS AGREEMENT] 

 IN WITNESS
WHEREOF, the parties hereto have executed this SECOND AMENDED AND RESTATED INVESTOR RIGHTS
AGREEMENT as of the date set forth in the first paragraph hereof. 
  

			
	INVESTORS:
	
	NORMAN L ROGERS LIVING TRUST
		
	By:	 	 /s/ Norman L Rogers

	Name: Norman L Rogers
	Title: TTEE

 [SIGNATURE PAGE TO AMENDED
AND RESTATED INVESTOR RIGHTS AGREEMENT] 

 IN WITNESS WHEREOF, the
parties hereto have executed this SECOND AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT as of the date set forth in the
first paragraph hereof. 
  

			
	INVESTORS:
	
	ONE EARTH CAPITAL, LLC
		
	By:	 	 /s/ David Herry Jacobs

	Name: David Herry Jacobs
	Title: Managing Member

 [SIGNATURE PAGE TO AMENDED
AND RESTATED INVESTOR RIGHTS AGREEMENT] 

 IN WITNESS
WHEREOF, the parties hereto have executed this SECOND AMENDED AND RESTATED INVESTOR RIGHTS
AGREEMENT as of the date set forth in the first paragraph hereof. 
  

			
	INVESTORS:
	
	MARTIN PANCHAUD
		
	By:	 	 /s/ Martin Panchaud

	Name: Martin Panchaud
	Title:	 	 

 [SIGNATURE PAGE TO AMENDED
AND RESTATED INVESTOR RIGHTS AGREEMENT] 

 IN WITNESS WHEREOF, the
parties hereto have executed this SECOND AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT as of the date set forth in the
first paragraph hereof. 
  

			
	INVESTORS:
	
	 POLYCOMP TRUST COMPANY CUSTODIAN FBO

EVELYN FALLON IRA

		
	By:	 	 /s/ Edith Irvin

	Name: Edith Irvin
	Title: IRA Compliance Specialist

 [SIGNATURE PAGE TO AMENDED
AND RESTATED INVESTOR RIGHTS AGREEMENT] 

 IN WITNESS WHEREOF, the
parties hereto have executed this SECOND AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT as of the date set forth in the
first paragraph hereof. 
  

			
	INVESTORS:
	
	 SAFFRON HILL VENTURES LP

SAFFRON HILL VENTURES 2 LP

		
	By:	 	 /s/ Ranjeet Bhatia

	Name: Ranjeet Bhatia
	Title: General Partner

 [SIGNATURE PAGE TO AMENDED
AND RESTATED INVESTOR RIGHTS AGREEMENT] 

 IN WITNESS
WHEREOF, the parties hereto have executed this SECOND AMENDED AND RESTATED INVESTOR RIGHTS
AGREEMENT as of the date set forth in the first paragraph hereof. 
  

			
	INVESTORS:
	
	STUART MILL VENTURE PARTNERS, L.P.
		
	By:	 	 /s/ Lawrence A. Hough 

	Name: Lawrence A. Hough
	Title: Managing Director

 [SIGNATURE PAGE TO AMENDED
AND RESTATED INVESTOR RIGHTS AGREEMENT] 

 IN WITNESS
WHEREOF, the parties hereto have executed this SECOND AMENDED AND RESTATED INVESTOR RIGHTS
AGREEMENT as of the date set forth in the first paragraph hereof. 
  

			
	INVESTORS:
	
	THORNER VENTURES
		
	By:	 	 /s/ Tom Thorner

	Name: Tom Thorner
	Title: Managing Partner

 [SIGNATURE PAGE TO AMENDED
AND RESTATED INVESTOR RIGHTS AGREEMENT] 

 IN WITNESS WHEREOF, the
parties hereto have executed this SECOND AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT as of the date set forth in the
first paragraph hereof. 
  

			
	INVESTORS:
	
	 
		
	By:	 	 /s/ Todd Thorner

	Name: Todd Thorner
	Title:                          
                                         
                           

 [SIGNATURE PAGE TO AMENDED
AND RESTATED INVESTOR RIGHTS AGREEMENT] 

 IN WITNESS
WHEREOF, the parties hereto have executed this SECOND AMENDED AND RESTATED INVESTOR RIGHTS
AGREEMENT as of the date set forth in the first paragraph hereof. 
  

			
	INVESTORS:
	
	VALLEY DALE INVESTMENTS LP
		
	By:	 	 /s/ Daniel B. Hrdy

	Name: Daniel B. Hrdy
	Title: Asst. Secy.

 [SIGNATURE PAGE TO AMENDED
AND RESTATED INVESTOR RIGHTS AGREEMENT] 

 IN WITNESS WHEREOF, the
parties hereto have executed this SECOND AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT as of the date set forth in the
first paragraph hereof. 
  

			
	INVESTORS:
	
	JOSEPH E. WHITTERS
		
	By:	 	/s/ Joseph E. Whitters
	Name: Joseph E. Whitters
	Title: Investor

 [SIGNATURE PAGE TO AMENDED
AND RESTATED INVESTOR RIGHTS AGREEMENT] 

 Exhibit A 
 SERIES A INVESTORS 
  

			
	 NAME AND ADDRESS
	  	 SHARES OF
SERIES A
 PREFERRED STOCK

		
	 CPV PARTNERS PLEDGE FUND, LP (A-2)
	  	601,902
		
	 ONE EARTH CAPITAL, LLC
	  	963,043
		
	 SAFFRON HILL VENTURES L.P.
	  	601,902
		
	 CALVERT SOCIAL INVESTMENT FUND EQUITY
PORTFOLIO
 Attn: Jean-Luc Park
	  	240,761
		
	 NORMAN L. ROGERS LIVING TRUST DATED
NOVEMBER 23, 1998
	  	150,595
		
	 WILLIAM DALE YOUNG & SONS TRUCKING
AND NURSERY MONEY PURCHASE PENSION
	  	121,647

			
	 CVV PARTNERS L.P.
	  	120,380
		
	 FULCRUM FINANCIAL LLC
	  	120,380
		
	 LABRADOR VENTURES V-B, LP
	  	120,381
		
	 VALLEY OAK INVESTMENTS, LP
	  	120,380
		
	 DAVIS MONTESSORI SCHOOL SERVICES DEFINED
BENEFIT PENSION PLAN
	  	112,155
		
	 DANIEL S. KOELLEN
	  	67,301
		
	 KATE ISA
	  	60,520
		
	 CARLA H. SKODINSKI
	  	60,507

			
	 MICHAEL M. FIELDMAN
	  	60,507
		
	 STONE GOSSARD
	  	60,190
		
	 PAMELA G. MARRONE AND MICHAEL J.
ROGERS
	  	51,745
		
	 FOUR BOYS’ INVESTMENTS
	  	48,152
		
	 JOSEPH E. WHITTERS
	  	55,810
		
	 JAMES A. SCHLINDWEIN
	  	52,111
		
	 JSS MANAGEMENT CO. LTD.
	  	52,111
		
	 PETE PRICE AND SUSAN E. PRICE
	  	44,676
		
	 RICHARD E. AND MARY EVELYNE ROMINGER
	  	37,486

			
	 CAMILLE CHAN TRUST DATED MARCH 28,
2002
	  	37,222
		
	 ARTHUR BERNDT
	  	37,214
		
	 WILLIAM KEITH BLADEN AND DOROTEA
BLADEN
	  	37,206
		
	 CESPED 1992 FAMILY TRUST DATED 2/26/92
	  	30,095
		
	 YASSO REVOCABLE TRUST
	  	30,095
		
	 ANTHONY S. SICA
	  	30,095
		
	 CHARLES W. CUNNINGHAM AND DEBORAH L.
DUNHAM
	  	25,079
		
	 THOMAS J. SPALDING AND BARBARA J.
SPALDING
	  	25,021
		
	 RICHARD C. DORF
	  	24,245

			
	 RONALD D. RANDOLPH-WALL LIVING TRUST
	  	24,076
		
	 JULIE IONE MORRIS 2001 TRUST DATED
14 SEPTEMBER 2001
	  	24,076
		
	 MIRANDA KAISER
	  	18,346
		
	 JULIE VERSMAN
	  	18,267
		
	 VIDANO 2005 FAMILY TRUST
	  	18,057
		
	 AKERS WATERMAN TRUST
	  	18,057
		
	 DAVID B. LEHN AND CARLA C. LEHN
	  	17,930
		
	 ZINGARO TRUST
	  	15,016
		
	 GEORGE A. BARDEN AND SHARON M. BARDEN
	  	14,886

			
	 NICOLE BIGGART AND JAMES F. BIGGART
	  	14,883
		
	 ANDREW B. HARGADON
	  	14,883
		
	 WEST AMERICA BANK CUSTODIAN FBO EVELYN
FALLON
	  	14,883
		
	 THE FARMAN REVOCABLE TRUST
	  	14,883
		
	 SINTHYA PENN
	  	14,883
		
	 THORNER VENTURES
	  	14,883
		
	 JOANNE YAWITZ GODINO TRUST
	  	14,883
		
	 MARGARET S. BURNS
	  	12,413
		
	 THE LARKEY FAMILY TRUST
	  	12,299

			
	 JOAN DOYLE AND MARIA FANELLI
	  	12,260
		
	 CHARLES R. RAWLS
	  	12,204
		
	 DANIEL B. COHEN
	  	12,157
		
	 FLORENCE H. MARRONE TOD PAMELA G. MARRONE
	  	12,157
		
	 SALMONSON FAMILY TRUST
	  	12,104
		
	 WELLS FARGO BANK C/F MARK ENGSTROM DEFINED
BENEFIT PLAN (2372 0522)
	  	12,104
		
	 NASH FAMILY TRUST U/D/T 3/18/80
AS AMENDED
	  	12,038
		
	 ROGER E. MERRIAM
	  	12,038

			
	 GOFF GROUP INVESTMENTS, LP
	  	12,038
		
	 JULIE AND CRAIG MCNAMARA
	  	12,038
		
	 LANDINGS INVESTMENT PARTNERS, LLC
	  	12,038
		
	 THE DAWN U. DARO AND PHILIP A. DARO
TRUST
	  	12,038
		
	 JACK B. IRVINE III
	  	12,038

  

 EXHIBIT B 

SERIES B INVESTORS 
  

			
	 NAME AND ADDRESS
	  	 SHARES OF
SERIES B
 PREFERRED STOCK

	 INITIAL CLOSE AUGUST 5, 2008
	  	
		
	 STUART MILL VENTURE PARTNERS,
L.P.
	  	1,618,249
		
	 CGI OPPORTUNITY FUND II, L.P.
	  	1,618,249
		
	 ONE EARTH CAPITAL, LLC
	  	1,294,599
		
	 THE SAFFRON HILL VENTURES 2 LIMITED
PARTNERSHIP
	  	970,950
		
	 CPV PARTNERS PLEDGE FUND, LP (A-5)
	  	582,570
		
	 CVV PARTNERS L.P.
	  	64,730

			
	 WELLS FARGO BANK C/F MARK ENGSTROM DEFINED
BENEFIT PLAN (2372 0522)
	  	9,092
		
	 AKERS WATERMAN TRUST
	  	6,473
		
	 THE FARMAN REVOCABLE TRUST
	  	6,473
		
	 ETHAN LERNER
	  	34,280
		
	 WELLS FARGO IRA C/F JOHN VALENTINE
	  	32,797
		
	 CHARLES R. RAWLS
	  	27,586
		
	 TODD THORNER
	  	26,249

			
	 HANS R. HERREN AND BARBARA GEMMILL HERREN
REVOCABLE TRUST
	  	20,304
		
	 THOMAS J. SPALDING AND BARBARA J.
SPALDING
	  	17,090
		
	 FOUR BOYS’ INVESTMENTS
	  	17,051
		
	 PAMELA G. MARRONE AND MICHAEL J.
ROGERS
	  	16,955
		
	 THE LARKEY FAMILY TRUST
	  	13,178
		
	 AKERS WATERMAN TRUST
	  	6,858
		
	 RONALD D. RANDOLPH-WALL LIVING TRUST
	  	18,084
		
	SECOND CLOSE AUGUST 22, 2008	  	
		
	 NORMAN L. ROGERS LIVING TRUST
DATED
 NOVEMBER 23, 1998
	  	130,000

			
	 LABRADOR VENTURES V-B, LP
	  	97,095
		
	 DANIEL S. KOELLEN
	  	32,365
		
	 CESPED 1992 FAMILY TRUST DATED 2/26/92
	  	22,606
		
	 PAMELA G. MARRONE AND MICHAEL J.
ROGERS
	  	21,913
		
	 PETE PRICE AND SUSAN E. PRICE
	  	19,500
		
	 JULIE IONE MORRIS 2001 TRUST DATED
14 SEPTEMBER 2001
	  	16,183
		
	 THOMAS J. SPALDING AND BARBARA J.
SPALDING
	  	16,182
		
	 DAVIS MONTESSORI SCHOOL SERVICES DEFINED
BENEFIT PENSION PLAN
	  	11,651

			
	 THORNER VENTURES
	  	11,179
		
	 NASH FAMILY TRUST U/D/T 3/18/80
AS AMENDED
	  	10,000
		
	 CHARLES W. CUNNINGHAM AND DEBORAH L.
DUNHAM
	  	6,473
		
	 JOAN DOYLE AND MARIA FANELLI
	  	6,473
		
	 FOUR BOYS’ INVESTMENTS
	  	6,473
		
	 ROGER E. MERRIAM
	  	6,473
		
	 JULIE VERSMAN
	  	6,473
		
	THIRD CLOSE SEPTEMBER 3, 2008	  	
		
	 CALVERT SOCIAL INVESTMENT FUND
EQUITY PORTFOLIO
	  	181,244

			
	 JSS MANAGEMENT CO. LTD.
	  	19,419
		
	 THE LEHN 2007 LIVING TRUST
	  	6,473
		
	 SINTHYA PENN
	  	6,473

  

 EXHIBIT C 

SERIES C INVESTORS 
  

			
	 NAME AND ADDRESS
	  	
SHARES OF SERIES C 

PREFERRED STOCK

		
	 STUART MILL VENTURE PARTNERS, L.P.
	  	1,180,627
		
	 CGI OPPORTUNITY FUND II, L.P.
	  	1,180,627
		
	 SAFFRON HILL VENTURES 2, L.P.
	  	1,092,080
		
	 ONE EARTH CAPITAL, LLC
	  	590,313
		
	
NORMAN L. ROGERS LIVING TRUST DATED 
NOVEMBER 23, 1998
	  	70,837
		
	 JULIA N. HARTE
	  	59,031

			
	CVV PARTNERS L.P.	  	29,516
		
	ETHAN LERNER	  	29,515
		
	MARTIN PANCHAUD	  	25,000
		
	CAMILLE CHAN TRUST DATED MARCH 28, 2002	  	14,758
		
	MIRANDA KAISER	  	8,989
		
	THE FARMAN REVOCABLE TRUST	  	5,904
		
	ENTRUST ADMINISTRATIVE SERVICES INC. FBO NANCY L. LAWS TRADITIONAL IRA
#1228090104	  	59,717
		
	ENTRUST ADMINISTRATIVE SERVICES INC. FBO NANCY L. LAWS ROTH IRA
#1228090205	  	59,717

			
	THOMAS J. SPALDING AND BARBARA J. SPALDING	  	29,975
		
	STONE GOSSARD	  	29,709
		
	WELLS FARGO IRA C/F JOHN VALENTINE	  	17,763
		
	PAMELA G. MARRONE AND MICHAEL J. ROGERS	  	14,948
		
	LARS TOMANEK AND RUTH E. ROMINGER	  	14,871
		
	THE RICHARD AND MARY ROMINGER COMMUNITY PROPERTY
TRUST	  	14,861
		
	DANIEL S. KOELLEN	  	14,809
		
	CHARLES R. RAWLS	  	14,793
		
	FOUR BOYS’ INVESTMENTS	  	14,780

			
	 SINTHYA PENN
	  	10,487
		
	 JOAN DOYLE AND MARIA FANELLI
	  	9,267
		
	 THORNER VENTURES
	  	239,078
		
	 TODD THORNER
	  	5,904
		
	 CPV PARTNERS PLEDGE FUND, LP SERIES A-8
	  	177,095EX-4.3

 Exhibit 4.3 
 THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AND HAVE BEEN ACQUIRED FOR INVESTMENT AND NOT WITH A VIEW TO, OR IN CONNECTION WITH, THE SALE OR
DISTRIBUTION THEREOF. NO SUCH SALE OR DISPOSITION MAY BE EFFECTED WITHOUT AN EFFECTIVE REGISTRATION STATEMENT RELATED THERETO OR AN OPINION OF COUNSEL FOR THE COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED UNDER THE SECURITIES ACT OF 1933.

  

							
	Date of Issuance: October 26, 2006	  	Number of Shares:	  	“See Section 1 (e)”
		 		  	                         
   (Subject to Adjustment)

 MARRONE ORGANIC INNOVATIONS, INC., A DELAWARE CORPORATION 

Series A Preferred Stock Purchase Warrant 
 Marrone Organic Innovations, Inc., a Delaware Corporation. (the “Company”), for value received, hereby certifies that VENCORE SOLUTIONS
LLC, a Delaware Limited Liability Company, its successors and or its registered assigns (the “Registered Holder”), is entitled, subject to the terms set forth below, to purchase from the Company up to Fifteen Thousand
Dollars and 00/100 ($15,000.00) worth of shares of Series A Preferred Stock of the Company (“Preferred Stock”), at a purchase price per share as defined in Section 1e) below, subject to adjustment as hereinafter provided, at any time after
the date hereof and on or before the earlier of (a) Seven and a half (7.5) years from the date of issuance hereof, or (b) the closing of the initial public offering (“IPO”) of the Company’s Common Stock pursuant to a
registration statement under the Securities Act of 1933, as amended (the “Securities Act”). The number and types of shares purchasable upon exercise of this Warrant, and the purchase price per share, each as adjusted from time to time
pursuant to the provisions of this Warrant, are hereinafter referred to as the “Warrant Stock” and the “Purchase Price,” respectively. 
 1. Exercise. 
     a) This Warrant may be
exercised by the Registered Holder, in whole or in part, by surrendering this Warrant, with the purchase form appended hereto as Exhibit A duly executed by such Registered Holder or by such Registered Holder’s duly authorized attorney,
at the principal office of the Company, or at such other office or agency as the Company may designate, accompanied by payment of the Purchase Price payable in respect of the number of shares of Warrant Stock purchased upon such exercise.

     b) Each exercise of this Warrant shall be deemed to have been effected immediately prior to the close
of business on the day on which this Warrant shall have been surrendered to the Company as provided in Section 1(a) above. At such time, the person or persons in whose name or names any certificates for Warrant Stock shall be issuable upon
such exercise as provided in Section 1(d) below shall be deemed to have become the holder or holders of record of the Warrant Stock represented by such certificates. 

 c) Net Issue Exercise. 

    (i) In lieu of exercising this Warrant in the manner provided above in Section 1(a), the Registered Holder
may elect to receive shares equal to the value of this Warrant (or the portion thereof being canceled) by surrender of this Warrant at the principal office of the Company together with notice of such election in which event the Company shall issue
to holder a number of shares of Preferred Stock computed using the following formula: 
 X= Y (A – B) 

    A 
  

	Where	X = The number of shares of Preferred Stock to be issued to the Registered Holder. 

 

	    	Y = The number of shares of Preferred Stock purchasable under this Warrant (at the date of such calculation). 

 

	    	A = The fair market value of one share of Preferred Stock (at the date of such calculation). 

 

	    	B = The Purchase Price (as adjusted to the date of such calculation). 

     (ii) For purposes of this Section 1(c), prior to the closing on the IPO the fair market value of Preferred Stock shall be the price per share, which the Company could obtain
from a willing buyer for the shares sold by the Company from authorized but unissued shares, as such price shall be determined in good faith by the Board of Directors. Following the IPO the market value will be determined by the value of the
Company’s Common Stock. 
 d) As soon as practicable after the exercise of this Warrant in full or in part, and in any
event within thirty (30) days thereafter, the Company at its expense will cause to be issued in the name of, and delivered to, the Registered Holder, or as such Holder (upon payment by such Holder of any applicable transfer taxes) may direct:

 (i) a certificate or certificates for the number of shares of Warrant Stock to which such Registered Holder shall be
entitled; and 
 (ii) in case such exercise is in part only, a new warrant or warrants (dated the date hereof) of like tenor,
calling in the aggregate on the face or faces thereof for the number of shares of Warrant Stock equal (without giving effect to any adjustment therein) to the number of such shares called for on the face of this Warrant minus the number of such
shares purchased by the Registered Holder upon such exercise as provided in Section 1(a) above. 
 e) The Registered Holder
shall have the right to purchase up to a limited number of shares of the Company’s Preferred Stock (the “Warrant Stock”) based on the “Purchase Price” (per share) such that if all of the Warrant Stock is purchased by the
Registered Holder the total price paid by the Registered Holder will be Fifteen Thousand Dollars and 00/100 ($15,000.00) and the number of shares Holder receives shall equal $15,000.00 divided by the Purchase Price. The Purchase Price

  

			
	Confidential	  	Page 2 of 11

 
shall be the per share price of shares of the Company’s Series A Preferred Stock as sold by the Company to investors in the Company’s current/next equity round (the
“Offering”). 
 2. Adjustments. 

a) If outstanding shares of the Company’s Preferred Stock shall be subdivided into a greater number of shares or a dividend in
Preferred Stock shall be paid in respect of Preferred Stock, the Purchase Price in effect immediately prior to such subdivision or at the record date of such dividend shall simultaneously with the effectiveness of such subdivision or immediately
after the record date of such dividend be proportionately reduced. If outstanding shares of Preferred Stock shall be combined into a smaller number of shares, the Purchase Price in effect immediately prior to such combination shall, simultaneously
with the effectiveness of such combination, be proportionately increased. When any adjustment is required to be made in the Purchase Price, the number of shares of Warrant Stock purchasable upon the exercise of this Warrant shall be changed to the
number determined by dividing (i) an amount equal to the number of shares issuable upon the exercise of this Warrant immediately prior to such adjustment, multiplied by the Purchase Price in effect immediately prior to such adjustment, by
(ii) the Purchase Price in effect immediately after such adjustment. 
 b) In case of any reclassification or change of the
outstanding securities of the Company or of any reorganization of the Company (or any other corporation the stock or securities of which are at the time receivable upon the exercise of this Warrant) or any similar corporate reorganization on or
after the date hereof, then and in each such case the holder of this Warrant, upon the exercise hereof at any time after the consummation of such reclassification, change, reorganization, merger or conveyance, shall be entitled to receive, in lieu
of the stock or other securities and property receivable upon the exercise hereof prior to such consummation, the stock or other securities or property to which such holder would have been entitled upon such consummation if such holder had exercised
this Warrant immediately prior thereto, all subject to further adjustment as provided in paragraph (a); and in each such case, the terms of this Section 2 shall be applicable to the shares of stock or other securities properly receivable upon
the exercise of this Warrant after such consummation. 
 c) When any adjustment is required to be made in the Purchase Price,
the Company shall promptly mail to the Registered Holder a certificate setting forth the Purchase Price after such adjustment and setting forth a brief statement of the facts requiring such adjustment. Such certificate shall also set forth the kind
and amount of stock or other securities or property into which this Warrant shall be exercisable following the occurrence of any of the events specified in Section 2(a) or (b) above. 

d) In order to avoid doubt, it is acknowledged that the holder of this Warrant shall be entitled to the benefit of all adjustments in the
number of shares of Common Stock of the Company issuable upon conversion of the Preferred Stock of the Company which occur prior to the exercise of this Warrant, including without limitation, any increase in the number of shares of Common Stock
issuable upon conversion as a result of a dilutive issuance of capital stock. 

  

			
	Confidential	  	Page 3 of 11

 e) The Warrant Stock will be afforded the same antidilution protection as the Company’s
Series A Preferred Stock as set forth in the Company’s Articles of Incorporation, as amended from time to time. 
 3.
Transfers. 
 a) Subject to the provisions of Section 3(b) hereto, this Warrant and all rights hereunder are
transferable, in whole or in part, upon surrender of the Warrant with a properly executed assignment (in the form of Exhibit B hereto) at the principal office of the Company. 

b) Each holder of this Warrant acknowledges that this Warrant, the Warrant Stock and the Common Stock of the Company have not been
registered under the Securities Act, and agrees not to sell, pledge, distribute, offer for sale, transfer or otherwise dispose of this Warrant, any Warrant Stock issued upon its exercise or any Common Stock issued upon conversion of the Warrant
Stock in the absence of (i) an effective registration statement under the Act as to this Warrant, such Warrant Stock or such Common Stock and registration or qualification of this Warrant, such Warrant Stock or such Common Stock under any
applicable Blue Sky or state securities law then in effect, or (ii) an opinion of counsel, satisfactory to the Company, that such registration and qualification are not required. Each certificate or other instrument for Warrant Stock issued
upon the exercise of this Warrant shall bear a legend substantially to the foregoing effect. 
 c) Until any transfer of this
Warrant is made in the warrant register, the Company may treat the Registered Holder of this Warrant as the absolute owner hereof for all purposes; provided, however, that if and when this warrant is properly assigned in blank, the
Company may (but shall not be required to) treat the bearer hereof as the absolute owner hereof for all purposes, notwithstanding any notice to the contrary. Except as otherwise expressly provided herein, the provisions hereof shall inure to the
benefit of, and be binding upon, the successors, assigns, heirs, executors and administrators of the parties hereto. 
 d) The
Company will maintain a register containing the names and addresses of the Registered Holders of this Warrant. Any Registered Holder may change such Registered Holder’s address as shown on the warrant register by written notice to the Company
requesting such change. 
 4. No Impairment. The Company will not, by amendment of its charter or through
reorganization, consolidation, merger, dissolution, sale of assets or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant, but will at all times in good faith assist in the carrying
out of all such terms and in the taking of all such action as may be necessary or appropriate in order to protect the rights of the holder of this Warrant against impairment. 
 5. Liquidating Dividends. If the Company pays a dividend or makes a distribution on the Preferred Stock payable otherwise than in cash out of earnings or earned surplus (determined in
accordance with generally accepted accounting principles) except for a stock dividend payable in shares of Preferred Stock or other securities of the Company (a “Liquidating Dividend”), then the Company will pay or distribute to the
Registered Holder of this Warrant, upon the exercise hereof, in addition to the Warrant Stock purchased upon such exercise, the Liquidating Dividend which would have been paid to such Registered Holder if he had been the owner of record of such
shares of 

  

			
	Confidential	  	Page 4 of 11

 Warrant Stock immediately prior to the date on which a record was taken for such Liquidating Dividend or, if
no record was taken, the date as of which the record holders of Preferred Stock entitled to such dividends or distribution were determined. 
 6. Piggyback Registration Rights. 
 a) If the Company proposes to
register (including for this purpose a registration effected by the Company for stockholders other than the Registered Holder) any of its stock under the Securities Act in connection with the public offering of such securities solely for cash, the
Company shall, at such time, promptly give the Registered Holder written notice of such registration. Upon the written request of the Registered Holder given within twenty (20) days after mailing of such notice by the Company, the Company shall
cause to be registered under the Securities Act all of the shares of Common Stock issued upon conversion of the Warrant Stock (the “Registrable Securities”) that the Registered Holder has requested to be registered. Notwithstanding the
foregoing, if the total amount of securities, including Registrable Securities, requested by stockholders to be included in such offering exceeds the amount of securities sold other than by the Company that the underwriters determine in their sole
discretion is compatible with the success of the offering, then the Company shall be required to include in the offering only that number of such securities, including Registrable Securities, which the underwriters determine in their sole discretion
will not jeopardize the success of the offering (the securities so included to be apportioned pro rata among the selling stockholders according to the total amount of securities entitled to be included therein owned by each selling stockholder or in
such other proportions as shall mutually be agreed to by such selling stockholders). 
 b) The Company shall bear and pay all
expenses incurred in connection with any registration, filing or qualification of Registrable Securities with respect to the registrations hereunder, including (without limitation) all registration, filing, and qualification fees, printers’ and
accounting fees relating or apportionable thereto and the reasonable fees and disbursements of one counsel for the selling stockholders selected by them with the approval of the Company, which approval shall not be unreasonably withheld, but
excluding underwriting discounts and commissions relating to Registrable Securities. 
 c) The Company will indemnify each
Holder of Registrable Securities and each of its officers, directors and partners, and each person controlling such Holder, with respect to which such registration, qualification or compliance has been effected pursuant to this Warrant, against all
claims, losses, expenses, damages and liabilities (or actions in respect thereto) arising out of or based on any untrue statement (or alleged untrue statement) of a material fact contained in any prospectus, offering circular or other document
(including any related registration statement, notification or the like) incident to any such registration, qualification or compliance, or based on any omission (or alleged omission) to state therein a material fact required to be stated therein or
necessary to make the statement therein not misleading, or any violation or alleged violation by the Company of the Securities Act, the Securities Exchange Act of 1934 as amended (Exchange Act), or any state securities law applicable to the Company
or any rule or regulation promulgated under the Securities Act, the Exchange Act or any such state law and relating to action or inaction required of the Company in connection with any such registration, qualification of compliance, and will
reimburse each such Holder, each of its officers, directors and partners, and each person controlling such Holder, within a reasonable amount of time after incurred for any reasonable legal and any other expenses incurred in connection with
investigating, defending or settling any such claim, loss, 

  

			
	Confidential	  	Page 5 of 11

 
damage, liability or action; provided, however, that the indemnity agreement contained in this subsection shall not apply to amounts paid in settlement of any such claim, loss, damage, liability,
or action if such settlement is effected without the consent of the Company (which consent shall not be unreasonably withheld); and provided further, that the Company will not be liable in any such case to the extent that any such claim, loss,
damage or liability arises out of or is based on any untrue statement or omission based upon written information furnished to the Company by an instrument duly executed by such Holder specifically for use therein. The Company shall not, except with
the consent of Holder, consent to entry of any judgment or enter into any settlement which does not include as an unconditional term thereof the giving by the claimant or plaintiff to Holder a release from all liability with respect to such claim or
litigation. 
 d) To the extent permitted by law, each selling Holder will indemnify and hold harmless the Company, each of its
directors, each of its officers who has signed the registration statement, each person, if any, who controls the Company within the meaning of the Act, any underwriter, any other Holder selling securities in such registration statement, each officer
and director of any such other Holder and any controlling person of any such underwriter or other Holder, against any losses, claims, damages, or liabilities (joint or several) to which any of the foregoing persons may become subject, under the Act,
the 1934 Act or other federal or state law, insofar as such losses, claims, damages, or liabilities (or actions in respect thereto) arise out of or are based upon any Violation, in each case to the extent (and only to the extent) that such Violation
occurs in reliance upon and in conformity with written information furnished by such Holder, or by an officer or director of any such Holder expressly for use in connection with such registration; and each such Holder will pay any legal or other
expenses reasonably incurred by any person intended to be indemnified pursuant to this Section 5 (d), in connection with investigating or defending any such loss, claim, damage, liability, or action; provided, however, that the indemnity
agreement contained in this Section 5 (d) shall not apply to amounts paid in settlement of any such loss, claim, damage, liability or action if such settlement is effected without the consent of the Holder, which consent shall not be
unreasonably withheld; provided, further, that, in no event shall any indemnity under this Section 5 (d) exceed the gross proceeds from the offering received by such Holder net of underwriters commissions and discounts. 

e) At all times after the effective date of the first registration statement filed by the Company for the offering of its securities to
the general public, the Company agrees to use its commercially reasonable efforts to take such actions as are necessary and appropriate to make available to the Registered Holder the benefits of Rule 144 promulgated under the Securities Act and any
other rule or regulation of the Securities and Exchange Commission (the “SEC”) that may at any time permit the Registered Holder to sell securities of the Company to the public without registration, including filing with the SEC in a
timely manner all reports and other documents required under the Securities Act and the Securities Exchange Act of 1934. 
 f)
Any restrictions and obligations, including lock-up, indemnification, reduction in number of shares to be registered, on the holders of Series A in a piggyback registration would apply to the Holder of the Warrant to the extent the shares were
included in such registration 

  

			
	Confidential	  	Page 6 of 11

 7. Notices of Certain Transactions/Delivery of Certain Documents. 

The obligations in this Section 7 no longer apply if the Company (a) has closed the IPO, or (2) has been consolidated or merged with another
company (other than a consolidation or merger in which the Company is the surviving entity). 
 a) So long as Registered Holder
holds this Warrant and/or any of the Preferred Shares, the Company shall deliver to Registered Holder: 
 (i) Promptly after
mailing, copies of all notices or other written communications to the shareholders of the Company; and 
 (ii) Starting with
fiscal year 2007, within one hundred eighty (180) days after the end of each fiscal year of the Company, the annual reviewed financial statements of the Company certified by independent public accountants of recognized standing; and 

(iii) Within forty-five (45) days after the end of each of the first three quarters of each fiscal year, the Company’s
quarterly, unaudited financial statements. 
 b) In case: 

(i) the Company shall take a record of the holders of its Preferred Stock (or other stock or securities at the time deliverable upon the
exercise of this Warrant) for the purpose of entitling or enabling them to receive any dividend or other distribution, or to receive any right to subscribe for or purchase any shares of stock of any class or any other securities, or to receive any
other right, to subscribe for or purchase any shares of stock of any class or any other securities, or to receive any other right; or 
 (ii) of any capital reorganization of the Company, any reclassification of the capital stock of the Company, any consolidation or merger of the Company, any consolidation or merger of the Company with or
into another corporation (other than a consolidation or merger or reincorporation in which the Company is the surviving entity), or any transfer of all or substantially all of the assets of the Company; or 

(iii) of any redemption of the Preferred Stock or mandatory conversion of the Preferred Stock into Common Stock of the Company;

 then, and in each such case, the Company will mail or cause to be mailed to the Registered Holder of this Warrant a notice specifying, as the
case may be, (a) the date on which a record is to be taken for the purpose of such dividend, distribution or right, and stating the amount and character of such dividend, distribution or right, or (b) the effective date on which such
reorganization, reclassification, consolidation, merger, transfer, dissolution, liquidation, winding-up, redemption or conversion is to take place, and the time, if any is to be fixed, as of which the holders of record of Preferred Stock (or such
other stock or securities at the time deliverable upon such reorganization, reclassification, consolidation, merger, transfer, dissolution, liquidation, winding-up, redemption or conversion shall) shall be determined. Such notice shall be mailed at
least ten (10) days prior to the record date or effective date for the event specified in such notice. 

  

			
	Confidential	  	Page 7 of 11

 8. Reservation of Stock. The Company will at all times reserve and keep
available, solely for the issuance and delivery upon the exercise of this Warrant, such shares of Warrant Stock and other stock, securities and property, as from time to time shall be issuable upon the exercise of this Warrant. 

9. Exchange of Warrants. Upon the surrender by the Registered Holder of any Warrant or Warrants, properly endorsed,
to the Company at the principal office of the Company, the Company will, subject to the provisions of Section 3 hereof, issue and deliver to or upon the order of such Holder, at the Company’s expense, a new Warrant or Warrants of like
tenor, in the name of such Registered Holder or as such Registered Holder (upon payment by such Registered Holder of any applicable transfer taxes) may direct, calling in the aggregate on the face or faces thereof for the number of shares of
Preferred Stock called for on the face or faces of the Warrant or Warrants so surrendered. 
 10. Replacement of
Warrants. Upon receipt of evidence reasonably satisfactory to the Company of the loss, theft, destruction or mutilation of this Warrant and (in the case of loss, theft or destruction) upon delivery of an indemnity agreement (with surety if
reasonably required) in an amount reasonably satisfactory to the Company, or (in the case of mutilation) upon surrender and cancellation of this Warrant, the Company will issue, in lieu thereof, a new Warrant of like tenor. 

11. Mailing of Notices. Any notice required or permitted pursuant to this Warrant shall be in writing and shall be
deemed sufficient when delivered personally or sent by telegram or fax or forty-eight (48) hours after being deposited in the US mail, as certified or registered mail, with postage prepaid, addressed (a) if to the Registered Holder, to the
address of the Registered Holder most recently furnished in writing to the Company and (b) if to the Company, to the address set forth below or subsequently modified by written notice to the Registered Holder. 

12. No Rights as Stockholder. Until the exercise of this Warrant, the Registered Holder of this Warrant shall not
have or exercise any rights by virtue hereof as a stockholder of the Company. 
 13. No Fractional Shares.
No fractional shares of Preferred Stock will be issued in connection with any exercise hereunder. In lieu of any fractional shares which would otherwise be issuable, the Company shall pay cash equal to the product of such fraction multiplied by the
fair market value of one share of Preferred Stock on the date of exercise, as determined in good faith by the Company’s Board of Directors. 
 14. Amendment or Waiver. Any term of this Warrant may be amended or waived only by an instrument in writing signed by the party against which enforcement of the amendment or waiver is
sought. 
 15. Headings. The headings in this Warrant are for purposes of reference only and shall not
limit or otherwise affect the meaning of any provision of this Warrant. 

  

			
	Confidential	  	Page 8 of 11

 16. Governing Law. This Warrant shall be governed, construed and interpreted
in accordance with the laws of the State of California, without giving effect to principles of conflicts of law. In case any provision of this Warrant shall be invalid, illegal, or unenforceable, the validity, legality and enforceability of the
remaining provisions of this Warrant shall not in any way be affected or impaired thereby. 
 17. Entire
Agreement. Except as otherwise set forth herein, this Warrant and the other documents delivered pursuant hereto constitute the full and entire understanding and agreement between the parties with regard to the subject matter hereof.

  

			
	 MARRONE ORGANIC INNOVATIONS, INC.,
 A DELAWARE CORPORATION

		
	By:	 	/s/ Pamela G. Marrone
		 	PAMELA G. MARRONE, PH.D
		
	Address:	 	215 MADSON PLACE, SUITES B/C
		 	DAVIS, CA 95618
		
	Date of Issuance &	 	
	Date of Signature:	 	10-26-06

  

			
	Confidential	  	Page 9 of 11

 Exhibit A 
 PURCHASE FORM 
  

			
	 To:   MARRONE ORGANIC INNOVATIONS, INC.

A DELAWARE CORPORATION
	  	Dated:
                        

  

	1.	The undersigned hereby elects to purchase
                     shares of the Warrant Stock covered by the attached Warrant pursuant to the terms thereof, and (please indicate either
(a) or (b) below): 

  

	 	        (a)	tenders herewith payment in cash, check or wire transfer of the purchase price of such shares in full; or 

 

	 	        (b)	elects to effect such purchase through the Net Issue Exercise provision set forth in Section 1(c) of the attached Warrant. 

 

	2.	Please issue a certificate or certificates representing said shares in the name of the undersigned or in such other name or names as are specified below.

  

					
		 	Name:	 	 
			
		 	Address:	 	 
			
		 		 	 
			
		 		 	 

  
  

			
	Signature:	 	 
		
	Address:	 	 

  

  

			
	Confidential	  	Page 10 of 11

 Exhibit B 
 ASSIGNMENT FORM 
 FOR VALUE RECEIVED,
                                         
    hereby sells, assigns and transfers all of the rights of the undersigned under the attached Warrant with respect to the number of shares of Preferred Stock covered thereby set forth below, unto: 

 

					
	 Name of Assignee
	  	 Address
	  	 No. of Shares

 

									
		 		 	
					
	Dated:	 	 	 		 	Signature:	 	 
					
		 		 		 		 	 
		 		 		 		 	PRINT NAME OF SIGNOR
		 		 		 		 	
		 		 		 	Witness:	 	 
					
		 		 		 		 	 
		 		 		 		 	PRINT NAME OF WITNESS

  

			
	Confidential	  	Page 11 of 11

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00218-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00218-of-00352.parquet"}]]